<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Med</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Med</journal-id><journal-id journal-id-type="publisher-id">jcm</journal-id><journal-title-group><journal-title>Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2077-0383</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6723901</article-id><article-id pub-id-type="doi">10.3390/jcm8081092</article-id><article-id pub-id-type="publisher-id">jcm-08-01092</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Markers of Cancer Cell Invasion: Are They Good Enough?</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7283-0092</contrib-id><name><surname>Gerashchenko</surname><given-names>Tatiana S.</given-names></name><xref ref-type="aff" rid="af1-jcm-08-01092">1</xref><xref rid="c1-jcm-08-01092" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Novikov</surname><given-names>Nikita M.</given-names></name><xref ref-type="aff" rid="af1-jcm-08-01092">1</xref><xref ref-type="aff" rid="af2-jcm-08-01092">2</xref></contrib><contrib contrib-type="author"><name><surname>Krakhmal</surname><given-names>Nadezhda V.</given-names></name><xref ref-type="aff" rid="af3-jcm-08-01092">3</xref></contrib><contrib contrib-type="author"><name><surname>Zolotaryova</surname><given-names>Sofia Y.</given-names></name><xref ref-type="aff" rid="af2-jcm-08-01092">2</xref></contrib><contrib contrib-type="author"><name><surname>Zavyalova</surname><given-names>Marina V.</given-names></name><xref ref-type="aff" rid="af3-jcm-08-01092">3</xref><xref ref-type="aff" rid="af4-jcm-08-01092">4</xref></contrib><contrib contrib-type="author"><name><surname>Cherdyntseva</surname><given-names>Nadezhda V.</given-names></name><xref ref-type="aff" rid="af1-jcm-08-01092">1</xref><xref ref-type="aff" rid="af5-jcm-08-01092">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2923-9755</contrib-id><name><surname>Denisov</surname><given-names>Evgeny V.</given-names></name><xref ref-type="aff" rid="af1-jcm-08-01092">1</xref><xref ref-type="aff" rid="af6-jcm-08-01092">6</xref></contrib><contrib contrib-type="author"><name><surname>Perelmuter</surname><given-names>Vladimir M.</given-names></name><xref ref-type="aff" rid="af4-jcm-08-01092">4</xref></contrib></contrib-group><aff id="af1-jcm-08-01092"><label>1</label>Laboratory of Molecular Oncology and Immunology, Cancer Research Institute, Tomsk National Research Medical Center, 634009 Tomsk, Russia</aff><aff id="af2-jcm-08-01092"><label>2</label>Department of Cytology and Genetics, Tomsk State University, 634050 Tomsk, Russia</aff><aff id="af3-jcm-08-01092"><label>3</label>Department of Pathological Anatomy, Siberian State Medical University, 634050 Tomsk, Russia</aff><aff id="af4-jcm-08-01092"><label>4</label>Department of General and Molecular Pathology, Cancer Research Institute, Tomsk National Research Medical Center, 634009 Tomsk, Russia</aff><aff id="af5-jcm-08-01092"><label>5</label>Laboratory for Translational Cellular and Molecular Biomedicine, Tomsk State University, 634050 Tomsk, Russia</aff><aff id="af6-jcm-08-01092"><label>6</label>Department of Organic Chemistry, Tomsk State University, 634050 Tomsk, Russia</aff><author-notes><corresp id="c1-jcm-08-01092"><label>*</label>Correspondence:&#x000a0;&#x000a0;&#x000a0; <email>t_gerashchenko@oncology.tomsk.ru</email></corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2019</year></pub-date><volume>8</volume><issue>8</issue><elocation-id>1092</elocation-id><history><date date-type="received"><day>28</day><month>6</month><year>2019</year></date><date date-type="accepted"><day>22</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Invasion, or directed migration of tumor cells into adjacent tissues, is one of the hallmarks of cancer and the first step towards metastasis. Penetrating to adjacent tissues, tumor cells form the so-called invasive front/edge. The cellular plasticity afforded by different kinds of phenotypic transitions (epithelial&#x02013;mesenchymal, collective&#x02013;amoeboid, mesenchymal&#x02013;amoeboid, and <italic>vice versa</italic>) significantly contributes to the diversity of cancer cell invasion patterns and mechanisms. Nevertheless, despite the advances in the understanding of invasion, it is problematic to identify tumor cells with the motile phenotype in cancer tissue specimens due to the absence of reliable and acceptable molecular markers. In this review, we summarize the current information about molecules such as extracellular matrix components, factors of epithelial&#x02013;mesenchymal transition, proteases, cell adhesion, and actin cytoskeleton proteins involved in cell migration and invasion that could be used as invasive markers and discuss their advantages and limitations. Based on the reviewed data, we conclude that future studies focused on the identification of specific invasive markers should use new models one of which may be the intratumor morphological heterogeneity in breast cancer reflecting different patterns of cancer cell invasion.</p></abstract><kwd-group><kwd>cancer</kwd><kwd>invasion</kwd><kwd>invasive front</kwd><kwd>epithelial&#x02013;mesenchymal transition</kwd><kwd>heterogeneity</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-jcm-08-01092"><title>1. Introduction</title><p>Metastasis is a key feature of cancer and a &#x0201c;final chord&#x0201d; of the tumor progression [<xref rid="B1-jcm-08-01092" ref-type="bibr">1</xref>]. The ability for metastasis enables tumor cells to leave the primary site and disseminate throughout the body, causing severe organ failure and leading to death. Understanding the mechanisms underlying metastasis is extremely important for the development of highly effective cancer therapies [<xref rid="B2-jcm-08-01092" ref-type="bibr">2</xref>].</p><p>Metastasis is a complex process of stepwise events collectively termed the metastatic cascade and consisting of local invasion of tumor cells, intravasation to blood vessels, survival in the circulation, arrest at distant organs, extravasation into the parenchyma of distant tissues, micrometastasis formation, and metastatic colonization (macrometastasis) [<xref rid="B1-jcm-08-01092" ref-type="bibr">1</xref>,<xref rid="B2-jcm-08-01092" ref-type="bibr">2</xref>]. Invasion is the first step in the metastasis of tumor cells. From the morphological point of view, the invasion is a process during which malignant cells detach from the tumor mass, acquire the ability to actively move, and invade surrounding tissues through the adjacent basement membrane [<xref rid="B3-jcm-08-01092" ref-type="bibr">3</xref>]. The interface of tumor and host tissue, in other words, the deepest rim of cancerous tissue grown in adjacent non-cancerous tissues, is called an &#x0201c;invasive front (edge)&#x0201d; [<xref rid="B4-jcm-08-01092" ref-type="bibr">4</xref>]. Tumor cells constituting the invasive front are phenotypically different from cells in other tumor parts. Invasive front cells are believed to have a locomotor phenotype and demonstrate a variety of types and mechanisms of movement [<xref rid="B5-jcm-08-01092" ref-type="bibr">5</xref>,<xref rid="B6-jcm-08-01092" ref-type="bibr">6</xref>]. Tumor cells can move collectively or individually. The type of invasion depends on the molecular changes in tumor cells and the tumor microenvironment features [<xref rid="B7-jcm-08-01092" ref-type="bibr">7</xref>,<xref rid="B8-jcm-08-01092" ref-type="bibr">8</xref>,<xref rid="B9-jcm-08-01092" ref-type="bibr">9</xref>,<xref rid="B10-jcm-08-01092" ref-type="bibr">10</xref>]. The distinctive features of collective cell invasion include physical and functional relationships among tumor cells due to adhesion molecules as well as the presence of leader cells that are characterized by the mesenchymal phenotype and the ability to form lamellipodia, pull follower cells, and destroy the extracellular matrix (ECM) through production of proteases [<xref rid="B11-jcm-08-01092" ref-type="bibr">11</xref>,<xref rid="B12-jcm-08-01092" ref-type="bibr">12</xref>,<xref rid="B13-jcm-08-01092" ref-type="bibr">13</xref>]. Interestingly, according some reports, invasive leaders do not express molecular features of epithelial&#x02013;mesenchymal transition (EMT) [<xref rid="B14-jcm-08-01092" ref-type="bibr">14</xref>], but exhibit a basal epithelial gene program, that is enriched in cytokeratin-14 and the transcription factor p63 [<xref rid="B15-jcm-08-01092" ref-type="bibr">15</xref>,<xref rid="B16-jcm-08-01092" ref-type="bibr">16</xref>].</p><p>Individual invasion can occur through mesenchymal and amoeboid cell migration mechanisms [<xref rid="B17-jcm-08-01092" ref-type="bibr">17</xref>]. Sometimes, an intermediate amoeboid/mesenchymal (filopodial) cell migration mode is distinguished [<xref rid="B18-jcm-08-01092" ref-type="bibr">18</xref>]. In mesenchymal movement, tumor cells exhibit a pronounced fibroblast-like phenotype, high expression of integrins, synthesis of proteolytic enzymes, and activity of small GTPases Rac1 and Cdc42 that are necessary to form lamellipodia and actomyosin contractions [<xref rid="B7-jcm-08-01092" ref-type="bibr">7</xref>,<xref rid="B12-jcm-08-01092" ref-type="bibr">12</xref>]. In amoeboid movement, cells are not capable of proteolysis and adhesion of the ECM but demonstrate the enhanced activity of the actomyosin machinery and the formation of cell membrane protrusions (blebs), which allow cells to squeeze through tight spaces in the surrounding matrix. Amoeboid movement directly depends on Rho/ROCK cell signaling and activity of type II myosin [<xref rid="B13-jcm-08-01092" ref-type="bibr">13</xref>,<xref rid="B17-jcm-08-01092" ref-type="bibr">17</xref>,<xref rid="B19-jcm-08-01092" ref-type="bibr">19</xref>]. Tumor cells can transit from one cell migration phenotype to another via mesenchymal&#x02013;amoeboid (MAT) and amoeboid&#x02013;mesenchymal transition. The key role in these transitions is played by the balance of GTPases Rho and Rac, changes in expression of focal adhesion molecules and proteases, and ECM stiffness [<xref rid="B13-jcm-08-01092" ref-type="bibr">13</xref>]. Importantly, the Rho/Rac feedback loop, particularly balanced relative high RhoA and Rac1, is also responsible for the hybrid amoeboid/mesenchymal phenotype in migrating cells [<xref rid="B20-jcm-08-01092" ref-type="bibr">20</xref>].</p><p>EMT plays a key role in tumor dissemination. During EMT, tumor cells lose the epithelial phenotype and acquire the mesenchymal features and resistance to antitumor treatment; EMT also promotes immortalization and is involved in the prevention of apoptosis [<xref rid="B21-jcm-08-01092" ref-type="bibr">21</xref>,<xref rid="B22-jcm-08-01092" ref-type="bibr">22</xref>]. EMT is induced not only by molecular changes in tumor cells but also by cytokines and growth factors secreted by immune and stromal cells of the tumor microenvironment [<xref rid="B23-jcm-08-01092" ref-type="bibr">23</xref>,<xref rid="B24-jcm-08-01092" ref-type="bibr">24</xref>,<xref rid="B25-jcm-08-01092" ref-type="bibr">25</xref>,<xref rid="B26-jcm-08-01092" ref-type="bibr">26</xref>]. EMT may be incomplete (partial) when tumor cells still retain epithelial features but already acquire mesenchymal traits. During partial EMT, cells are described as a hybrid, with an intermediate epithelial/mesenchymal phenotype [<xref rid="B27-jcm-08-01092" ref-type="bibr">27</xref>]. Partial EMT has been reported for both single tumor cells and tumor buds (groups of up to five cells) that are a variant of collective invasion [<xref rid="B28-jcm-08-01092" ref-type="bibr">28</xref>]. The phenomenon &#x0201c;tumor budding&#x0201d; is regarded as a specific &#x0201c;signal&#x0201d; indicating the onset of cancer invasion and metastasis. The presence of tumor buds in the invasive front was found to be associated with increased metastasis and poor prognosis in various cancers [<xref rid="B28-jcm-08-01092" ref-type="bibr">28</xref>,<xref rid="B29-jcm-08-01092" ref-type="bibr">29</xref>,<xref rid="B30-jcm-08-01092" ref-type="bibr">30</xref>,<xref rid="B31-jcm-08-01092" ref-type="bibr">31</xref>,<xref rid="B32-jcm-08-01092" ref-type="bibr">32</xref>,<xref rid="B33-jcm-08-01092" ref-type="bibr">33</xref>,<xref rid="B34-jcm-08-01092" ref-type="bibr">34</xref>].</p><p>Tumor cells can acquire the ability for migration not only through EMT but also through the so-called collective&#x02013;amoeboid transition (CAT) when cells detach from the tumor mass and acquire an amoeboid phenotype rather than a mesenchymal phenotype. CAT is known to be regulated by the core regulatory circuits underlying EMT (miR-200/miR-34) and MAT (Rac1/RhoA) [<xref rid="B35-jcm-08-01092" ref-type="bibr">35</xref>] and can be promoted by hypoxia-inducible factor 1 (HIF-1), which is accompanied by a decrease in E-cadherin expression [<xref rid="B36-jcm-08-01092" ref-type="bibr">36</xref>]. However, CAT still remains a poorly understood phenomenon.</p><p>Active migration of tumor cells is not the only mechanism for invasive tumor growth. There is the so-called passive invasion when cells penetrate adjacent tissues under pressure from other tumor cells during proliferation (expansive growth) or due to an increase in the ECM density caused by the production of fibronectin and collagen by cancer-associated fibroblasts [<xref rid="B37-jcm-08-01092" ref-type="bibr">37</xref>,<xref rid="B38-jcm-08-01092" ref-type="bibr">38</xref>]. The fact that many circulating tumor cells are apoptotic [<xref rid="B39-jcm-08-01092" ref-type="bibr">39</xref>,<xref rid="B40-jcm-08-01092" ref-type="bibr">40</xref>], may be considered as indirect evidence of passive invasion, whereas active invasion is associated with viable cells [<xref rid="B37-jcm-08-01092" ref-type="bibr">37</xref>].</p><p>Despite the fact that the mechanisms and types of cell migration and invasion have been described and studied quite well, there are currently no highly efficient and validated molecular markers for identification of migrating/invading tumor cells in tumors and, therefore, for assessment of their invasive potential. These markers could be used to identify patients at the high risk of distant metastasis and to prescribe therapy aimed at interrupting the metastatic process. In addition, these markers might represent targets for future therapeutics that block invasion and metastasis.</p><p>In this review, we systematized information about molecules that might be potential markers of tumor invasion and discussed the advantages and limitations of their use in clinical practice.</p></sec><sec id="sec2-jcm-08-01092"><title>2. Potential Markers of Cancer Cell Invasion</title><p>The literature reports numerous studies describing various molecules that may act as markers of tumor cell invasion. Conventionally, they may be subdivided into several groups: ECM components, EMT, cell&#x02013;cell and cell&#x02013;ECM molecules, proteases, and actin cytoskeleton proteins (<xref rid="jcm-08-01092-t001" ref-type="table">Table 1</xref>).</p><sec id="sec2dot1-jcm-08-01092"><title>2.1. ECM Components</title><p>The first barrier to tumor cell invasion is the basement membrane that is a 100&#x02013;300 nm thick ECM structure consisting of laminins, type IV collagen, and other non-cellular components, on which epithelial cells proliferate and differentiate [<xref rid="B41-jcm-08-01092" ref-type="bibr">41</xref>,<xref rid="B42-jcm-08-01092" ref-type="bibr">42</xref>,<xref rid="B43-jcm-08-01092" ref-type="bibr">43</xref>,<xref rid="B44-jcm-08-01092" ref-type="bibr">44</xref>]. Impaired integrity of the basement membrane is a histological marker indicating that carcinoma has acquired invasive properties [<xref rid="B12-jcm-08-01092" ref-type="bibr">12</xref>,<xref rid="B41-jcm-08-01092" ref-type="bibr">41</xref>,<xref rid="B43-jcm-08-01092" ref-type="bibr">43</xref>]. A key component of the basement membrane, laminin-5, consists of &#x003b1;3, &#x003b2;3, and &#x003b3;2 chains and plays a significant role in migration and invasion of tumor cells [<xref rid="B43-jcm-08-01092" ref-type="bibr">43</xref>,<xref rid="B45-jcm-08-01092" ref-type="bibr">45</xref>,<xref rid="B46-jcm-08-01092" ref-type="bibr">46</xref>,<xref rid="B47-jcm-08-01092" ref-type="bibr">47</xref>,<xref rid="B48-jcm-08-01092" ref-type="bibr">48</xref>]. The interaction between laminin-5 and tumor cell integrins leads to the release of proteases and degradation of the basement membrane and ECM [<xref rid="B43-jcm-08-01092" ref-type="bibr">43</xref>,<xref rid="B47-jcm-08-01092" ref-type="bibr">47</xref>,<xref rid="B49-jcm-08-01092" ref-type="bibr">49</xref>,<xref rid="B50-jcm-08-01092" ref-type="bibr">50</xref>,<xref rid="B51-jcm-08-01092" ref-type="bibr">51</xref>]. The laminin-5 &#x003b3;2 chain monomer, which is considered as one of the most characteristic markers of invasion is found in the invasive front of different cancers [<xref rid="B51-jcm-08-01092" ref-type="bibr">51</xref>,<xref rid="B52-jcm-08-01092" ref-type="bibr">52</xref>]. For example, laminin &#x003b3;2 expression combined with MMP-7 and EGFR expression in the invasive front is associated with gastric cancer aggressiveness [<xref rid="B43-jcm-08-01092" ref-type="bibr">43</xref>]. In gastric cancer, cytoplasmic expression of laminin &#x003b3;2 in tumor cells is related to lymph node metastasis and advanced stage [<xref rid="B53-jcm-08-01092" ref-type="bibr">53</xref>]; in gallbladder cancer, stromal laminin &#x003b3;2 expression is associated with a poor prognosis [<xref rid="B54-jcm-08-01092" ref-type="bibr">54</xref>]. Laminin &#x003b3;2 is also expressed in the invasive front of breast, pancreatic, colon, lung, and other cancers [<xref rid="B46-jcm-08-01092" ref-type="bibr">46</xref>,<xref rid="B51-jcm-08-01092" ref-type="bibr">51</xref>,<xref rid="B52-jcm-08-01092" ref-type="bibr">52</xref>,<xref rid="B55-jcm-08-01092" ref-type="bibr">55</xref>,<xref rid="B56-jcm-08-01092" ref-type="bibr">56</xref>].</p><p>After penetrating the basement membrane, invading cells enter the ECM. Fibronectin is the major ECM component that plays a key role in the stimulation of cell growth, adhesion, and cell migration. On the one hand, fibronectin forms a physical barrier for migrating cells; on the other hand, its interaction with tumor cell integrins, mainly with &#x003b1;5&#x003b2;1, triggers ECM proteolysis through secreting MMP-2 and MMP-9 [<xref rid="B42-jcm-08-01092" ref-type="bibr">42</xref>,<xref rid="B112-jcm-08-01092" ref-type="bibr">112</xref>]. Fibronectin was demonstrated to be involved in the regulation of cell invasion and migration in various cancers [<xref rid="B113-jcm-08-01092" ref-type="bibr">113</xref>] and expressed at the invasive front of oral and head and neck squamous cell carcinomas [<xref rid="B60-jcm-08-01092" ref-type="bibr">60</xref>,<xref rid="B61-jcm-08-01092" ref-type="bibr">61</xref>].</p><p>The tenascin C protein also belongs to ECM glycoproteins; however, it is mainly active during embryogenesis. In the adult body, tenascin C is found only in some types of connective tissue (tendons, ligaments, etc.). Interestingly, tenascin C is often expressed in the invasive front of breast, lung, liver, and gallbladder cancers, as well as melanoma, and is associated with a poor prognosis particularly decreased recurrence-free and overall survival and a high rate of metastasis [<xref rid="B57-jcm-08-01092" ref-type="bibr">57</xref>,<xref rid="B62-jcm-08-01092" ref-type="bibr">62</xref>].</p><p>Despite the proven association of basement membrane and ECM components with invasiveness, their role as markers of tumor invasion is ambiguous. For example, laminin &#x003b3;2 expression is not always observed in the invasive front. According to Sentani [<xref rid="B43-jcm-08-01092" ref-type="bibr">43</xref>], cytoplasmic laminin &#x003b3;2 expression in the invasive front of gastric cancer occurs only in 25% of cases, and stromal expression is observed in 8% of cases. According to Garc&#x000ed;a-Solano [<xref rid="B58-jcm-08-01092" ref-type="bibr">58</xref>], laminin &#x003b3;2 expression in tumor buds at the invasive front of colorectal adenocarcinoma is found only in 17&#x02013;57% of cases. In addition to the invasive front, laminin &#x003b3;2 is also found in the basement membrane and cytoplasm of tumor cells, outside the invasive front [<xref rid="B46-jcm-08-01092" ref-type="bibr">46</xref>]. Fibronectin and tenascin C are also expressed not only in the invasive front [<xref rid="B57-jcm-08-01092" ref-type="bibr">57</xref>,<xref rid="B59-jcm-08-01092" ref-type="bibr">59</xref>].</p></sec><sec id="sec2dot2-jcm-08-01092"><title>2.2. EMT Factors</title><p>EMT is common to almost all cancers, but the transition is rarely implemented in full [<xref rid="B67-jcm-08-01092" ref-type="bibr">67</xref>]. Partial EMT is mainly typical of tumor cell clusters. However, there is evidence that single migrating cells may be in partial EMT. During partial EMT, tumor cells show co-expression of molecules of epithelial (E-cadherin, EpCAM, cytokeratin 7, miR-200, miR-34, etc.) and mesenchymal (N-cadherin, vimentin, ZEB, SNAIL, etc.) phenotypes. Cells in a partial EMT are capable of both adhesion and migration [<xref rid="B27-jcm-08-01092" ref-type="bibr">27</xref>,<xref rid="B28-jcm-08-01092" ref-type="bibr">28</xref>,<xref rid="B67-jcm-08-01092" ref-type="bibr">67</xref>].</p><p>Overexpression of EMT markers is often observed in the invasive front of various cancers [<xref rid="B63-jcm-08-01092" ref-type="bibr">63</xref>]. Nevertheless, molecules involved or associated with EMT are characterized by a low diagnostic value in assessing the invasive potential of tumors. Snail and Twist transcription factors are unstable molecules and undergo rapid proteasomal degradation [<xref rid="B64-jcm-08-01092" ref-type="bibr">64</xref>,<xref rid="B65-jcm-08-01092" ref-type="bibr">65</xref>]. In contrast, according to our data, Snail and Twist are totally expressed in breast tumor, without any selectivity in the invasive front [<xref rid="B66-jcm-08-01092" ref-type="bibr">66</xref>]. Vimentin, which is considered a marker of the final EMT stage, may not be expressed in invasive carcinomas at all [<xref rid="B67-jcm-08-01092" ref-type="bibr">67</xref>]. Furthermore, EMT is not always necessary for invasion and metastasis. In Snail and Twist knockout mice, tumor dissemination and the number of metastases are comparable to those in control mice [<xref rid="B114-jcm-08-01092" ref-type="bibr">114</xref>]. Therefore, the presence of EMT cannot always answer the question whether the tumor cell migrates at a given time.</p><p>However, it should be understood that EMT is a complex process in which each step is thought to be regulated by a distinct set of transcription factors and molecular circuits overlapping to each other and generating specific phenotypes [<xref rid="B115-jcm-08-01092" ref-type="bibr">115</xref>,<xref rid="B116-jcm-08-01092" ref-type="bibr">116</xref>]. The picture is complicated by the fact that EMT transcription factors control other cellular events, including apoptosis and stemness [<xref rid="B116-jcm-08-01092" ref-type="bibr">116</xref>]. Moreover, induction of an EMT transcription factor is known to be sufficient to induce single-cell dissemination without orchestrating the molecular EMT program and with retaining epithelial identity [<xref rid="B16-jcm-08-01092" ref-type="bibr">16</xref>,<xref rid="B117-jcm-08-01092" ref-type="bibr">117</xref>]. Thus, further studies are needed to explore molecular mechanisms underlying each EMT module, namely cell motility, and to find markers that could be used to assess the invasive potential of tumor cells. In addition, it is necessary to consider the fact that cells are capable of amoeboid and hybrid amoeboid/mesenchymal movement. Therefore, a perfect method for determining the invasive phenotype in tumor cells is the simultaneous assessment of markers of mesenchymal and amoeboid migration.</p></sec><sec id="sec2dot3-jcm-08-01092"><title>2.3. Cell&#x02013;Cell and Cell&#x02013;ECM Interaction Molecules</title><p>Adhesion molecules, such as integrins and the cadherin-catenin complex, are the key components of tumor invasion. Changes in the activity of cadherins, which are proteins involved in the formation of cell&#x02013;cell contacts, is a characteristic feature of invasive growth. E-cadherin, which forms adherens junctions in an epithelial cell layer, is repressed by Snail, Slug, and Twist transcription factors during EMT [<xref rid="B64-jcm-08-01092" ref-type="bibr">64</xref>]. The loss of E-cadherin and the nuclear localization of &#x003b2;-catenin, involved in signaling to the actin cytoskeleton [<xref rid="B118-jcm-08-01092" ref-type="bibr">118</xref>], were observed in tumor cells at the invasive front in various cancers [<xref rid="B69-jcm-08-01092" ref-type="bibr">69</xref>]. Nuclear accumulation of &#x003b2;-catenin in tumor cells in the invasive front and in vessels was found to be a powerful predictor of liver metastasis in colorectal cancer [<xref rid="B70-jcm-08-01092" ref-type="bibr">70</xref>,<xref rid="B71-jcm-08-01092" ref-type="bibr">71</xref>]. However, the loss of E-cadherin expression is probably not an indispensable prerequisite for invasiveness of tumor cells [<xref rid="B72-jcm-08-01092" ref-type="bibr">72</xref>] and, therefore, cannot be used as a marker for invasive growth, at least for some cancers. Moreover, in some tumors, a loss of E-cadherin has been shown to be detrimental to invasion and metastasis. For example, the presence of E-cadherin is a specific feature of a highly aggressive form of breast cancer, inflammatory carcinoma, and needed for successful invasion and metastatic colonization of bone by tumor cells [<xref rid="B119-jcm-08-01092" ref-type="bibr">119</xref>]. In this regard, analysis of more effective markers is needed to assess the invasive tumor potential, along with markers of amoeboid movement, as mentioned above.</p><p>The key event initiating production of metalloproteinases is the interaction of integrins with ECM components. The main ligands for integrins are fibronectin (&#x003b1;5&#x003b2;1, &#x003b1;v&#x003b2;3, and &#x003b1;4&#x003b2;1 integrins), collagens (&#x003b1;1&#x003b2;1, &#x003b1;2&#x003b2;1, and &#x003b1;11&#x003b2;1), and laminins (&#x003b1;2&#x003b2;1, &#x003b1;3&#x003b2;1, &#x003b1;6&#x003b2;1, and &#x003b1;6&#x003b2;4) [<xref rid="B41-jcm-08-01092" ref-type="bibr">41</xref>,<xref rid="B64-jcm-08-01092" ref-type="bibr">64</xref>,<xref rid="B120-jcm-08-01092" ref-type="bibr">120</xref>,<xref rid="B121-jcm-08-01092" ref-type="bibr">121</xref>,<xref rid="B122-jcm-08-01092" ref-type="bibr">122</xref>,<xref rid="B123-jcm-08-01092" ref-type="bibr">123</xref>]. For example, &#x003b1;3&#x003b2;1 integrin activates MMP-9 synthesis through interaction with laminins and triggers reorganization of the actin cytoskeleton [<xref rid="B124-jcm-08-01092" ref-type="bibr">124</xref>]; &#x003b1;6&#x003b2;1 is involved in tumor invasion via activation of the urokinase plasminogen activator (uPA) receptor and MMP-2 [<xref rid="B125-jcm-08-01092" ref-type="bibr">125</xref>]. Laminin-5 is the best-characterized ligand for &#x003b1;3&#x003b2;1 integrin. &#x003b1;6&#x003b2;4 integrin is involved in the regulation of tumor cell migration through activation of the Rho-A signaling cascade [<xref rid="B121-jcm-08-01092" ref-type="bibr">121</xref>]. Binding of fibronectin to &#x003b1;5&#x003b2;1 integrin activates MMP-1 and stimulates migration through the ILK/Akt and GSK3&#x003b2;/Snail/E-cadherin signaling pathways [<xref rid="B121-jcm-08-01092" ref-type="bibr">121</xref>,<xref rid="B126-jcm-08-01092" ref-type="bibr">126</xref>]. Fibronectin-mediated migration is also associated with &#x003b1;v&#x003b2;3 integrin. &#x003b1;v&#x003b2;3 integrin is involved in activation of MMP-2 [<xref rid="B127-jcm-08-01092" ref-type="bibr">127</xref>] and, under stress conditions, can trigger a ligand-independent signaling cascade leading to activation of NF-&#x003ba;B and Slug, acquisition of a stem phenotype, and promotion of migration [<xref rid="B126-jcm-08-01092" ref-type="bibr">126</xref>].</p><p>Expression of integrins changes during tumor progression and is often elevated in the invasive front of tumors: &#x003b1;v&#x003b2;3 in melanoma [<xref rid="B75-jcm-08-01092" ref-type="bibr">75</xref>], &#x003b1;v&#x003b2;6 in colon and head and neck cancers [<xref rid="B73-jcm-08-01092" ref-type="bibr">73</xref>,<xref rid="B76-jcm-08-01092" ref-type="bibr">76</xref>], and &#x003b1;6&#x003b2;4 in non-small cell lung cancer [<xref rid="B74-jcm-08-01092" ref-type="bibr">74</xref>]. Furthermore, high expression of integrins in tumor cells may promote metastasis. For example, &#x003b1;2&#x003b2;1 enhances metastasis of rhabdomyosarcoma in nude mice after intravenous or subcutaneous injection [<xref rid="B128-jcm-08-01092" ref-type="bibr">128</xref>], whereas &#x003b1;3&#x003b2;1 promotes lung metastasis through binding to laminin-5 in an exposed basement membrane in the pulmonary vasculature [<xref rid="B50-jcm-08-01092" ref-type="bibr">50</xref>].</p><p>Signaling pathways activated by different integrins may lead to the same biological effects, while an individual contribution of each of the integrins is different. In neuroblastoma, tumor cell migration can be activated either via FAK-mediated &#x003b1;5&#x003b2;1 integrin signaling or via a FAK-independent pathway involving &#x003b1;4&#x003b2;1 integrin. Both signaling pathways lead to the induction of Src family protein kinases [<xref rid="B129-jcm-08-01092" ref-type="bibr">129</xref>,<xref rid="B130-jcm-08-01092" ref-type="bibr">130</xref>].</p><p>The use of integrins as markers of invasive growth is complicated by the fact that the same integrins can participate in both invasion and other biological processes [<xref rid="B78-jcm-08-01092" ref-type="bibr">78</xref>]. For example, &#x003b1;6&#x003b2;1 integrin, apart from involvement in tumor invasion, also participates in Ca<sup>2+</sup> signaling [<xref rid="B131-jcm-08-01092" ref-type="bibr">131</xref>] and platelet adhesion upon damage to the vascular wall [<xref rid="B132-jcm-08-01092" ref-type="bibr">132</xref>].</p><p>There is evidence that changes in expression of other cell interaction proteins may be a marker of invasive tumor cells. Galectins, membrane glycoproteins, bound to integrins, laminins, and fibronectin, are used by cells to interact with each other and with the ECM [<xref rid="B47-jcm-08-01092" ref-type="bibr">47</xref>,<xref rid="B133-jcm-08-01092" ref-type="bibr">133</xref>]. Galectin-1 is involved in the regulation of cell adhesion and migration, on the one hand, through stimulation of MMP-2 and MMP-9 and, on the other hand, through activation of a small Rho GTPase Cdc42, which promotes the formation of actin filopodia. Increased expression of galectin-1 is associated with high invasiveness of lung adenocarcinoma and observed in the invasive front of oral squamous cell carcinoma and glioblastoma [<xref rid="B47-jcm-08-01092" ref-type="bibr">47</xref>,<xref rid="B79-jcm-08-01092" ref-type="bibr">79</xref>,<xref rid="B80-jcm-08-01092" ref-type="bibr">80</xref>]. However, galectins have effects not only on tumor cells but also on immune cells promoting inflammation or dampening T cell-mediated immune responses [<xref rid="B77-jcm-08-01092" ref-type="bibr">77</xref>]. The L1 cell adhesion molecule (L1CAM), which is involved in &#x003b2;-catenin/TCF signaling, is necessary for cell migration and invasion. Normally, L1CAM is present only in the nervous tissue, but its expression is induced in tumor cells. Increased expression of L1CAM was found in many cancers, including the invasive front of colorectal and pancreatic cancers [<xref rid="B81-jcm-08-01092" ref-type="bibr">81</xref>,<xref rid="B82-jcm-08-01092" ref-type="bibr">82</xref>]. Nevertheless, L1CAM can have a static function as a cell adhesion molecule and its expression is associated with good cancer prognosis [<xref rid="B83-jcm-08-01092" ref-type="bibr">83</xref>,<xref rid="B134-jcm-08-01092" ref-type="bibr">134</xref>].</p></sec><sec id="sec2dot4-jcm-08-01092"><title>2.4. Serine Proteases and Matrix Metalloproteinases</title><p>One of the main systems responsible for ECM proteolysis is the plasminogen activation system that triggers a powerful serine protease, plasmin. The central component of this system is the uPA and its receptor (uPAR), the interaction of which stimulates proteolysis of plasminogen to plasmin [<xref rid="B135-jcm-08-01092" ref-type="bibr">135</xref>,<xref rid="B136-jcm-08-01092" ref-type="bibr">136</xref>]. uPA is believed to play a significant role in tumor invasion and metastasis [<xref rid="B135-jcm-08-01092" ref-type="bibr">135</xref>,<xref rid="B136-jcm-08-01092" ref-type="bibr">136</xref>,<xref rid="B137-jcm-08-01092" ref-type="bibr">137</xref>]. Experiments in model animals demonstrated that inhibition of uPA and/or the uPA/uPAR interaction slows down metastasis [<xref rid="B135-jcm-08-01092" ref-type="bibr">135</xref>]. In contrast, expression of uPAR is associated with tumor invasion and is found in stromal and tumor cells in the invasive front of oral and skin squamous cell carcinomas [<xref rid="B84-jcm-08-01092" ref-type="bibr">84</xref>,<xref rid="B85-jcm-08-01092" ref-type="bibr">85</xref>].</p><p>Metalloproteinases are involved in proteolytic degradation of the basement membrane and ECM. MMP-7 activates MMP-2 and MMP-9 gelatinases exhibiting proteolytic activity against collagen IV, laminins, proteoglycans, and fibronectin [<xref rid="B138-jcm-08-01092" ref-type="bibr">138</xref>]. Expression of MMPs is observed during cancer cell invasion [<xref rid="B13-jcm-08-01092" ref-type="bibr">13</xref>,<xref rid="B41-jcm-08-01092" ref-type="bibr">41</xref>]. MMP-7-positive tumor cells are predominantly found in the invasive front of gastric cancer, while their number is much higher in aggressive and late-stage tumors [<xref rid="B90-jcm-08-01092" ref-type="bibr">90</xref>,<xref rid="B91-jcm-08-01092" ref-type="bibr">91</xref>]. MMP-7 is also expressed in the invasive front of colon cancer and correlates with tumor stage [<xref rid="B56-jcm-08-01092" ref-type="bibr">56</xref>,<xref rid="B91-jcm-08-01092" ref-type="bibr">91</xref>,<xref rid="B92-jcm-08-01092" ref-type="bibr">92</xref>]. Elevated MMP-2 and MMP-9 levels are observed in the invasive front of melanoma, endometrial cancer, and ovarian cancer [<xref rid="B89-jcm-08-01092" ref-type="bibr">89</xref>,<xref rid="B93-jcm-08-01092" ref-type="bibr">93</xref>]. High MMP-2 and MMP-9 expression is also observed in the invasive front of head and neck squamous cell carcinoma [<xref rid="B88-jcm-08-01092" ref-type="bibr">88</xref>,<xref rid="B94-jcm-08-01092" ref-type="bibr">94</xref>]. Assessment of MMP-2 and MMP-9 expression in the invasive tumor front may be helpful in the differentiation of verrucous carcinoma and squamous cell carcinoma of the oral cavity [<xref rid="B139-jcm-08-01092" ref-type="bibr">139</xref>].</p><p>However, increased expression of uPA and MMPs is not a unique feature of invasive tumor cells and may be observed in other physiological processes. The components of the uPA system can be involved in the early stages of tumor formation and can increase cell proliferation, inhibit apoptosis, etc. [<xref rid="B86-jcm-08-01092" ref-type="bibr">86</xref>]. MMPs are mediators between tumor cells and the microenvironment [<xref rid="B87-jcm-08-01092" ref-type="bibr">87</xref>]. MMP-9 produced by inflammatory cells is involved in the proteolytic activation of anti-inflammatory cytokines TGF-&#x003b2;2 and TGF-&#x003b2;3, and MMP-2 and MMP-14 participate in the activation of TGF-&#x003b2;1 [<xref rid="B87-jcm-08-01092" ref-type="bibr">87</xref>,<xref rid="B140-jcm-08-01092" ref-type="bibr">140</xref>,<xref rid="B141-jcm-08-01092" ref-type="bibr">141</xref>]. MMP-2, MMP-9, and MMP-14 indirectly modulate TGF-&#x003b2; activity by cleaving an ECM component, the latent TGF-&#x003b2; binding protein 1 [<xref rid="B87-jcm-08-01092" ref-type="bibr">87</xref>,<xref rid="B142-jcm-08-01092" ref-type="bibr">142</xref>]. MMP-7 inhibits apoptosis and reduces the efficacy of chemotherapy by cleaving Fas ligands on the surface of cells exposed to doxorubicin [<xref rid="B87-jcm-08-01092" ref-type="bibr">87</xref>,<xref rid="B143-jcm-08-01092" ref-type="bibr">143</xref>]. MMP-2 and MMP-9 are also involved in the regulation of angiogenesis and lymphangiogenesis [<xref rid="B87-jcm-08-01092" ref-type="bibr">87</xref>]. MMP-9 secreted by inflammatory cells modulates bioavailability of VEGF to the VEGFR2 receptor [<xref rid="B87-jcm-08-01092" ref-type="bibr">87</xref>,<xref rid="B144-jcm-08-01092" ref-type="bibr">144</xref>]. Experiments in mice demonstrated the role of MMP-9 in triggering the angiogenic switch and in vasculogenesis [<xref rid="B87-jcm-08-01092" ref-type="bibr">87</xref>,<xref rid="B145-jcm-08-01092" ref-type="bibr">145</xref>,<xref rid="B146-jcm-08-01092" ref-type="bibr">146</xref>]. Therefore, the multifunctionality of MMPs reduces their significance as markers of invasive growth.</p></sec><sec id="sec2dot5-jcm-08-01092"><title>2.5. Actin Cytoskeleton Proteins</title><p>Proteins involved in actin cytoskeleton remodeling play an important role in the mechanisms of tumor cell migration and invasion [<xref rid="B147-jcm-08-01092" ref-type="bibr">147</xref>]. The ezrin protein is a connecting link between actin filaments and membrane proteins involved in cell&#x02013;cell adhesion and migration [<xref rid="B148-jcm-08-01092" ref-type="bibr">148</xref>]. Ezrin was demonstrated to be localized together with the podoplanin in filopodia, stimulating cellular invasion [<xref rid="B149-jcm-08-01092" ref-type="bibr">149</xref>], and expressed in the invasive front of lung cancer [<xref rid="B95-jcm-08-01092" ref-type="bibr">95</xref>]. Many studies reported that upregulation of Ezrin is a negative prognostic factor in various cancers. However, there is an opposite data indicating the involvement of negative or reduced expression of Ezrin in cancer progression [<xref rid="B96-jcm-08-01092" ref-type="bibr">96</xref>]. This contradiction can be explained by the fact that Ezrin is implicated in the regulation not only of cell motility but also of cell adhesion, ion channels, cell proliferation, etc. [<xref rid="B150-jcm-08-01092" ref-type="bibr">150</xref>].</p><p>The WAVE2 protein is involved in actin filament reorganization and lamellipodia formation and was shown to colocalize with Arp2 at the invasive front of breast cancer [<xref rid="B97-jcm-08-01092" ref-type="bibr">97</xref>,<xref rid="B147-jcm-08-01092" ref-type="bibr">147</xref>].</p><p>Cortactin regulates cortical actin cytoskeleton dynamics by stabilizing F-actin networks and promoting actin polymerization via activating the Arp2/3 complex [<xref rid="B47-jcm-08-01092" ref-type="bibr">47</xref>,<xref rid="B151-jcm-08-01092" ref-type="bibr">151</xref>]. According to in vitro and in vivo experiments, cortactin promotes invasion of head and neck tumors [<xref rid="B151-jcm-08-01092" ref-type="bibr">151</xref>], and its high expression is found in the invasive front of oral and laryngeal tumors [<xref rid="B98-jcm-08-01092" ref-type="bibr">98</xref>,<xref rid="B99-jcm-08-01092" ref-type="bibr">99</xref>].</p><p>The MENA protein regulates actin polymerization and cell migration. An elevated level of the MENA<sup>inv</sup> isoform, which is involved in the formation of invadopodia due to phosphorylation of cortactin and activation of the N-WASP/Arp2/3 complex, is found in invasive cells of human tumors and animal tumor models and is associated with a high risk of metastasis [<xref rid="B100-jcm-08-01092" ref-type="bibr">100</xref>,<xref rid="B152-jcm-08-01092" ref-type="bibr">152</xref>,<xref rid="B153-jcm-08-01092" ref-type="bibr">153</xref>].</p><p>Fascin-1 is an actin-binding protein involved in filopodia formation. It is highly expressed in nervous tissue and is normally absent in epithelial cells. However, a high level of fascin-1 is found in many malignant neoplasms of the liver, gallbladder, stomach, intestines, lung, breast, etc., and is a marker of poor prognosis [<xref rid="B154-jcm-08-01092" ref-type="bibr">154</xref>,<xref rid="B155-jcm-08-01092" ref-type="bibr">155</xref>]. Increased expression of fascin-1 is found in the invasive front of liver, colon, cervical, and endometrial cancers and is associated with a high risk of metastasis [<xref rid="B101-jcm-08-01092" ref-type="bibr">101</xref>,<xref rid="B102-jcm-08-01092" ref-type="bibr">102</xref>,<xref rid="B103-jcm-08-01092" ref-type="bibr">103</xref>,<xref rid="B104-jcm-08-01092" ref-type="bibr">104</xref>].</p></sec><sec id="sec2dot6-jcm-08-01092"><title>2.6. Other Proteins</title><p>In the invasive front, there are highly proliferating tumor cells, which probably facilitate the more efficient dissemination of the tumor. Expression of Ki-67, a cell proliferation marker, was shown to be elevated in the invasive front of oral and endometrial cancers [<xref rid="B6-jcm-08-01092" ref-type="bibr">6</xref>,<xref rid="B105-jcm-08-01092" ref-type="bibr">105</xref>,<xref rid="B106-jcm-08-01092" ref-type="bibr">106</xref>]. In breast cancer, nuclear expression of Ki-67 is two-fold higher in the invasive front than in other parts of the tumor and is associated with metastasis to bones and liver [<xref rid="B107-jcm-08-01092" ref-type="bibr">107</xref>]. Increased proliferation of tumor cells in the invasive front is also indicated by elevated expression of FGFR2 that is involved in the induction of signaling pathways affecting division, growth, and differentiation of cells, as demonstrated in colorectal and cervical cancers [<xref rid="B109-jcm-08-01092" ref-type="bibr">109</xref>,<xref rid="B110-jcm-08-01092" ref-type="bibr">110</xref>]. However, there are also contradictory data on negative expression Ki-67 or the absence of differences in its level between the invasive front and the tumor center in oral and colorectal cancers [<xref rid="B56-jcm-08-01092" ref-type="bibr">56</xref>,<xref rid="B69-jcm-08-01092" ref-type="bibr">69</xref>,<xref rid="B108-jcm-08-01092" ref-type="bibr">108</xref>]. Moreover, FGFR2 is a multifunctional protein that regulates different biological processes such as proliferation, differentiation, etc. [<xref rid="B111-jcm-08-01092" ref-type="bibr">111</xref>].</p><p>At first glance, the prevalence of cell proliferation in the invasive front is in contradiction to the data that invading tumor cells are enriched in EMT markers [<xref rid="B63-jcm-08-01092" ref-type="bibr">63</xref>] because EMT typically associates with cell cycle arrest [<xref rid="B156-jcm-08-01092" ref-type="bibr">156</xref>]. However, in the invasive front, EMT-cell cycle connection can be broken. In other words, instead of &#x0201c;go-or-grow&#x0201d;, tumor cells follow &#x0201c;go-and-grow&#x0201d; behavior [<xref rid="B115-jcm-08-01092" ref-type="bibr">115</xref>,<xref rid="B157-jcm-08-01092" ref-type="bibr">157</xref>].</p><p>The search for tumor invasion markers is an important issue aimed at assessing the risk of cancer metastasis. The role of the discussed molecules as invasive markers is controversial in most cases. Most of these molecules are involved not only in invasive growth but also in processes not related to cell migration. Nevertheless, some molecules such as WAVE2, cortactin, MENAinv, and fascin-1 are promising candidates for future studies of their roles as cancer cell invasion markers. In any case, the search for more specific markers of invasive growth is needed. In this regard, we think that the emphasis on intratumor morphological heterogeneity typical of many cancers may be very productive. In particular, investigation of the molecular make-up of various invasive tumor structures may enable identification of new molecules associated with invasion of tumor cells.</p></sec></sec><sec id="sec3-jcm-08-01092"><title>3. Intratumor Morphological Heterogeneity as a Model for Studying Cancer Cell Invasion</title><p>Based on more than 10-year morphological studies and detailed analysis of various structural features of invasive carcinoma of no special type of the breast (IC NST, previously classified as invasive ductal carcinoma), we have concluded that there are two types of tumors: Nonstructural and structural (<xref ref-type="fig" rid="jcm-08-01092-f001">Figure 1</xref>). Nonstructural breast carcinomas are characterized by a monomorphic pattern and are represented by large solid areas connected to each other, with thin layers of stromal elements (<xref ref-type="fig" rid="jcm-08-01092-f001">Figure 1</xref>).</p><p>Structural tumors are characterized by a polymorphic pattern and a pronounced phenotypic variety of the infiltrative (invasive) and stromal components (<xref ref-type="fig" rid="jcm-08-01092-f001">Figure 1</xref>). In other words, structural tumors demonstrate significant morphological heterogeneity. In initial attempts to determine the potential morphological IC NST features associated with cancer progression, we identified five main types of the invasive component in the tumor: Tubular, alveolar, solid, and trabecular structures, and discrete groups of tumor cells [<xref rid="B158-jcm-08-01092" ref-type="bibr">158</xref>,<xref rid="B159-jcm-08-01092" ref-type="bibr">159</xref>,<xref rid="B160-jcm-08-01092" ref-type="bibr">160</xref>,<xref rid="B161-jcm-08-01092" ref-type="bibr">161</xref>]. The tubular structures are tube-shaped and lumen-containing arrangements of single rows of rather monomorphic tumor cells with round monomorphic nuclei. The alveolar structures are clusters of round or slightly irregular tumor cells of different sizes, often with polymorphic nuclei. The number of cells in alveolar structures varies from 5&#x02013;20. The solid structures are represented by large masses differing in size and shape, which consist of either small tumor cells with moderate cytoplasm and monomorphic nuclei or large cells with abundant cytoplasm and polymorphic nuclei. Although solid groups of tumor cells are a characteristic feature of nonstructural breast tumors, they are also observed in structural carcinomas. The trabecular structures are represented by either a single row of tumor cells (&#x02265;5 cells) or arrangements consisting of two rows of closely related monomorphic cells with moderate cytoplasm, which are parallel to each other. The discrete groups consist of small cell clusters (up to five cells) and single tumor cells (<xref ref-type="fig" rid="jcm-08-01092-f001">Figure 1</xref>). The size and shape of these cells and nuclei vary significantly [<xref rid="B158-jcm-08-01092" ref-type="bibr">158</xref>,<xref rid="B159-jcm-08-01092" ref-type="bibr">159</xref>,<xref rid="B160-jcm-08-01092" ref-type="bibr">160</xref>,<xref rid="B161-jcm-08-01092" ref-type="bibr">161</xref>].</p><p>Different morphological structures were shown to represent transcriptionally distinct tumor cell populations differing in the number of CD44<sup>+</sup>CD24<sup>&#x02212;</sup> cancer stem cells, epithelial and mesenchymal features, and enrichment of cancer invasion signaling pathways [<xref rid="B160-jcm-08-01092" ref-type="bibr">160</xref>]. Tubular and alveolar structures are similar in gene expression and demonstrate co-expression of epithelial and mesenchymal markers. The solid structures retain the epithelial features but demonstrate an increase in the mesenchymal traits and collective cell migration hallmarks. Trabecular and discrete groups are enriched in mesenchymal genes and cancer invasion pathways. CD44<sup>+</sup>CD24<sup>&#x02212;</sup> cells are less common in the discrete groups and more abundant in the alveolar and solid structures [<xref rid="B160-jcm-08-01092" ref-type="bibr">160</xref>]. Taken together, these data suggest that different morphological structures demonstrate varying degrees of EMT: From low in tubular, alveolar, and solid structures to advanced in trabecular and discrete groups of tumor cells [<xref rid="B160-jcm-08-01092" ref-type="bibr">160</xref>].</p><p>The intratumor morphological heterogeneity of breast cancer is not an occasional phenomenon and is strongly associated with disease prognosis and therapy efficacy. Breast tumors with either alveolar or trabecular structures are characterized by a high rate of lymph node metastasis [<xref rid="B161-jcm-08-01092" ref-type="bibr">161</xref>,<xref rid="B162-jcm-08-01092" ref-type="bibr">162</xref>]. In neoadjuvant chemotherapy (NAC), tumors with alveolar or trabecular structures often demonstrate a poor response [<xref rid="B162-jcm-08-01092" ref-type="bibr">162</xref>,<xref rid="B163-jcm-08-01092" ref-type="bibr">163</xref>] and an increased risk of distant metastasis [<xref rid="B162-jcm-08-01092" ref-type="bibr">162</xref>]. NAC-treated patients with alveolar or trabecular structures in breast tumors have decreased metastasis-free survival [<xref rid="B162-jcm-08-01092" ref-type="bibr">162</xref>].</p><p>In a longitudinal study of the morphological, molecular genetic and clinical features of breast cancer, we have clearly seen that the differences are present not only in the structural pattern of tumor tissue. It has become obvious that breast carcinoma is characterized by pronounced intratumor morphological heterogeneity when morphologically similar and almost identical structures can exhibit completely different expression profiles, and it may not be ruled out that this phenomenon may somehow affect the behavior of tumor [<xref rid="B66-jcm-08-01092" ref-type="bibr">66</xref>]. This conclusion prompted us to differentiate in more detail the previously described morphological structures.</p><p>A morphological analysis of structural IC NSTs revealed significant diversity and variability in solid groups of tumor cells, among which we identified two different variants: Solid structures with large torpedo-like sprouts and solid structures with small bud-like sprouts (<xref ref-type="fig" rid="jcm-08-01092-f001">Figure 1</xref>). The first variant is represented by various differently-sized, merging solid areas of tightly packed tumor cells connected with each other. In these structures, there are elongated, mostly triangular sprouts consisting of two&#x02013;three parallel cell rows. The base of torpedo-like sprouts is always pointed out to the body of solid structures, while the tip, consisting of one&#x02013;three tumor cells, penetrates to different depths to the stroma. Importantly, torpedo-like sprouts can be presented as structures independent of solid groups of tumor cells (<xref ref-type="fig" rid="jcm-08-01092-f001">Figure 1</xref>). Another variant of solid structures is represented by the large masses of tumor cells. However, a distinctive feature is that any edge of a solid structure comprises rounded or spherical bud-like sprouts consisting of five&#x02013;seven atypical cells penetrating to the stroma (<xref ref-type="fig" rid="jcm-08-01092-f001">Figure 1</xref>).</p><p>Thus, the structural diversity of the infiltrative component and the pronounced intratumor morphological heterogeneity in IC NST represent an attractive model for investigation of tumor cell invasion. The solid structures both with large torpedo-like and small bud-like sprouts, as well as trabecular structures, may be considered as a morphological manifestation of collective cell invasion. Discrete groups of tumor cells, mainly single tumor cells, are an example of individual cell invasion.</p></sec><sec sec-type="conclusions" id="sec4-jcm-08-01092"><title>4. Conclusions</title><p>Invasion is a key event towards the acquisition of the metastatic phenotype by tumor cells and an attractive target for anticancer therapy aimed at the prevention of metastasis. In in vitro studies, EMT has been proved to play an important role in the appearance of migrating and invading tumor cells. However, the cell movement mechanisms working in vitro are frequently not related to the invasive growth in vivo. Molecules that have been identified in vitro to be involved in cancer cell invasion do not demonstrate selective expression at the invasive front or at the tips of invasive structures where tumor cells are rather motile. Moreover, the expression of these molecules does not often demonstrate clinical significance for the prediction of cancer metastasis risk. Thus, the question how to identify invading tumor cells in human cancer specimens remains unanswered. In this regard, new effective models should be developed to investigate the mechanisms of cancer cell invasion. In our opinion, one of these models, at least in case of breast cancer, can be intratumor morphological heterogeneity which is a manifestation of different patterns of tumor cell invasion. The investigation of the molecular make-up of invasive structures of tumor cells and their microenvironment may provide valuable information about new molecules involved in the invasive growth and may identify novel prognostic markers and therapeutic targets.</p></sec></body><back><notes><title>Author Contributions</title><p>Conceptualization, V.M.P. and M.V.Z.; writing&#x02014;original draft preparation, T.S.G., N.M.N, N.V.K., and S.Y.Z.; writing&#x02014;review and editing, E.V.D.; supervision, N.V.C.</p></notes><notes><title>Funding</title><p>The study was supported by the Russian Science Foundation (grant #19-75-30016).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-jcm-08-01092"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D.</given-names></name><name><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group><article-title>Review Hallmarks of Cancer: The Next Generation</article-title><source>Cell</source><year>2011</year><volume>144</volume><fpage>646</fpage><lpage>674</lpage><?supplied-pmid 21376230?><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="B2-jcm-08-01092"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>W.G.</given-names></name><name><surname>Sanders</surname><given-names>A.J.</given-names></name><name><surname>Katoh</surname><given-names>M.</given-names></name><name><surname>Ungefroren</surname><given-names>H.</given-names></name><name><surname>Gieseler</surname><given-names>F.</given-names></name><name><surname>Prince</surname><given-names>M.</given-names></name><name><surname>Thompson</surname><given-names>S.K.</given-names></name><name><surname>Zollo</surname><given-names>M.</given-names></name><name><surname>Spano</surname><given-names>D.</given-names></name><name><surname>Dhawan</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Tissue invasion and metastasis: Molecular, biological and clinical perspectives</article-title><source>Semin. Cancer Biol.</source><year>2015</year><volume>35</volume><fpage>244</fpage><lpage>275</lpage></element-citation></ref><ref id="B3-jcm-08-01092"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahai</surname><given-names>E.</given-names></name></person-group><article-title>Mechanisms of cancer cell invasion</article-title><source>Curr. Opin. Genet. Dev.</source><year>2005</year><volume>15</volume><fpage>87</fpage><lpage>96</lpage><?supplied-pmid 15661538?><pub-id pub-id-type="pmid">15661538</pub-id></element-citation></ref><ref id="B4-jcm-08-01092"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e0;nkfalvi</surname><given-names>A.</given-names></name><name><surname>Piffk&#x000f2;</surname><given-names>J.</given-names></name></person-group><article-title>Prognostic and predictive factors in oral cancer: The role of the invasive tumour front</article-title><source>J. Oral Pathol. Med.</source><year>2000</year><volume>29</volume><fpage>291</fpage><lpage>298</lpage><?supplied-pmid 10947243?><pub-id pub-id-type="pmid">10947243</pub-id></element-citation></ref><ref id="B5-jcm-08-01092"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zlobec</surname><given-names>I.</given-names></name><name><surname>Lugli</surname><given-names>A.</given-names></name></person-group><article-title>Invasive front of colorectal cancer: Dynamic interface of pro-/anti-tumor factors</article-title><source>World J. Gastroenterol.</source><year>2009</year><volume>15</volume><fpage>5898</fpage><lpage>5906</lpage><?supplied-pmid 20014453?><pub-id pub-id-type="pmid">20014453</pub-id></element-citation></ref><ref id="B6-jcm-08-01092"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>C.</given-names></name><name><surname>Venegas</surname><given-names>B.</given-names></name></person-group><article-title>Histological and molecular aspects of oral squamous cell carcinoma</article-title><source>Oncol. Lett.</source><year>2014</year><volume>8</volume><fpage>7</fpage><lpage>11</lpage><?supplied-pmid 24959211?><pub-id pub-id-type="pmid">24959211</pub-id></element-citation></ref><ref id="B7-jcm-08-01092"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedl</surname><given-names>P.</given-names></name><name><surname>Wolf</surname><given-names>K.</given-names></name></person-group><article-title>Tumour-cell invasion and migration: Diversity and escape mechanisms</article-title><source>Nat. Rev. Cancer</source><year>2003</year><volume>3</volume><fpage>362</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">12724734</pub-id></element-citation></ref><ref id="B8-jcm-08-01092"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>K.</given-names></name><name><surname>Friedl</surname><given-names>P.</given-names></name></person-group><article-title>Molecular mechanisms of cancer cell invasion and plasticity</article-title><source>Br. J. Dermatol.</source><year>2006</year><volume>154</volume><fpage>11</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">16712711</pub-id></element-citation></ref><ref id="B9-jcm-08-01092"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krakhmal</surname><given-names>N.V.</given-names></name><name><surname>Zavyalova</surname><given-names>M.V.</given-names></name><name><surname>Denisov</surname><given-names>E.V.</given-names></name><name><surname>Vtorushin</surname><given-names>S.V.</given-names></name><name><surname>Perelmuter</surname><given-names>V.M.</given-names></name></person-group><article-title>Cancer invasion: Patterns and mechanisms</article-title><source>Acta Naturae</source><year>2015</year><volume>7</volume><fpage>17</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">26085941</pub-id></element-citation></ref><ref id="B10-jcm-08-01092"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lintz</surname><given-names>M.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>A.</given-names></name><name><surname>Reinhart-King</surname><given-names>C.A.</given-names></name></person-group><article-title>The Mechanics of Single Cell and Collective Migration of Tumor Cells</article-title><source>J. Biomech. Eng.</source><year>2017</year><volume>139</volume><fpage>021005</fpage></element-citation></ref><ref id="B11-jcm-08-01092"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Enomoto</surname><given-names>A.</given-names></name><name><surname>Asai</surname><given-names>N.</given-names></name><name><surname>Kato</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name></person-group><article-title>Collective invasion of cancer: Perspectives from pathology and development</article-title><source>Pathol. Int.</source><year>2016</year><volume>66</volume><fpage>183</fpage><lpage>192</lpage><?supplied-pmid 26897041?><pub-id pub-id-type="pmid">26897041</pub-id></element-citation></ref><ref id="B12-jcm-08-01092"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandya</surname><given-names>P.</given-names></name><name><surname>Orgaz</surname><given-names>J.L.</given-names></name><name><surname>Sanz-Moreno</surname><given-names>V.</given-names></name></person-group><article-title>Modes of invasion during tumour dissemination</article-title><source>Mol. Oncol.</source><year>2017</year><volume>11</volume><fpage>5</fpage><lpage>27</lpage><?supplied-pmid 28085224?><pub-id pub-id-type="pmid">28085224</pub-id></element-citation></ref><ref id="B13-jcm-08-01092"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedl</surname><given-names>P.</given-names></name><name><surname>Alexander</surname><given-names>S.</given-names></name></person-group><article-title>Cancer invasion and the microenvironment: Plasticity and reciprocity</article-title><source>Cell</source><year>2011</year><volume>147</volume><fpage>992</fpage><lpage>1009</lpage><?supplied-pmid 22118458?><pub-id pub-id-type="pmid">22118458</pub-id></element-citation></ref><ref id="B14-jcm-08-01092"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen-Ngoc</surname><given-names>K.-V.</given-names></name><name><surname>Cheung</surname><given-names>K.J.</given-names></name><name><surname>Brenot</surname><given-names>A.</given-names></name><name><surname>Shamir</surname><given-names>E.R.</given-names></name><name><surname>Gray</surname><given-names>R.S.</given-names></name><name><surname>Hines</surname><given-names>W.C.</given-names></name><name><surname>Yaswen</surname><given-names>P.</given-names></name><name><surname>Werb</surname><given-names>Z.</given-names></name><name><surname>Ewald</surname><given-names>A.J.</given-names></name></person-group><article-title>ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium</article-title><source>Proc. Natl. Acad. Sci.</source><year>2012</year><volume>109</volume><fpage>E2595</fpage><lpage>E2604</lpage><?supplied-pmid 22923691?><pub-id pub-id-type="pmid">22923691</pub-id></element-citation></ref><ref id="B15-jcm-08-01092"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>K.J.</given-names></name><name><surname>Gabrielson</surname><given-names>E.</given-names></name><name><surname>Werb</surname><given-names>Z.</given-names></name><name><surname>Ewald</surname><given-names>A.J.</given-names></name></person-group><article-title>Collective invasion in breast cancer requires a conserved basal epithelial program</article-title><source>Cell</source><year>2013</year><volume>155</volume><fpage>1639</fpage><lpage>1651</lpage><?supplied-pmid 24332913?><pub-id pub-id-type="pmid">24332913</pub-id></element-citation></ref><ref id="B16-jcm-08-01092"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>K.J.</given-names></name><name><surname>Ewald</surname><given-names>A.J.</given-names></name></person-group><article-title>Illuminating breast cancer invasion: Diverse roles for cell-cell interactions</article-title><source>Curr. Opin. Cell Biol.</source><year>2014</year><volume>30</volume><fpage>99</fpage><lpage>111</lpage><?supplied-pmid 25137487?><pub-id pub-id-type="pmid">25137487</pub-id></element-citation></ref><ref id="B17-jcm-08-01092"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pa&#x00148;kov&#x000e1;</surname><given-names>K.</given-names></name><name><surname>R&#x000f6;sel</surname><given-names>D.</given-names></name><name><surname>Novotn&#x000fd;</surname><given-names>M.</given-names></name><name><surname>Br&#x000e1;bek</surname><given-names>J.</given-names></name></person-group><article-title>The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells</article-title><source>Cell. Mol. Life Sci.</source><year>2010</year><volume>67</volume><fpage>63</fpage><lpage>71</lpage><?supplied-pmid 19707854?><pub-id pub-id-type="pmid">19707854</pub-id></element-citation></ref><ref id="B18-jcm-08-01092"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chikina</surname><given-names>A.S.</given-names></name><name><surname>Alexandrova</surname><given-names>A.Y.</given-names></name></person-group><article-title>The cellular mechanisms and regulation of metastasis formation</article-title><source>Mol. Biol.</source><year>2014</year><volume>48</volume><fpage>165</fpage><lpage>180</lpage></element-citation></ref><ref id="B19-jcm-08-01092"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paluch</surname><given-names>E.K.</given-names></name><name><surname>Raz</surname><given-names>E.</given-names></name></person-group><article-title>The role and regulation of blebs in cell migration</article-title><source>Curr. Opin. Cell Biol.</source><year>2013</year><volume>25</volume><fpage>582</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">23786923</pub-id></element-citation></ref><ref id="B20-jcm-08-01092"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Jolly</surname><given-names>M.K.</given-names></name><name><surname>Tsarfaty</surname><given-names>I.</given-names></name><name><surname>Onuchic</surname><given-names>J.</given-names></name><name><surname>Ben-Jacob</surname><given-names>E.</given-names></name></person-group><article-title>The three-way switch operation of Rac1/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition</article-title><source>Sci. Rep.</source><year>2014</year><volume>4</volume><fpage>1</fpage><lpage>11</lpage></element-citation></ref><ref id="B21-jcm-08-01092"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalluri</surname><given-names>R.</given-names></name><name><surname>Weinberg</surname><given-names>R.</given-names></name></person-group><article-title>The basics of epithelial-mesenchymal transition</article-title><source>J. Clin. Invest.</source><year>2009</year><volume>119</volume><fpage>1420</fpage><lpage>1428</lpage><?supplied-pmid 19487818?><pub-id pub-id-type="pmid">19487818</pub-id></element-citation></ref><ref id="B22-jcm-08-01092"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamouille</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Derynck</surname><given-names>R.</given-names></name></person-group><article-title>Molecular mechanisms of epithelial&#x02013;mesenchymal transition</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2014</year><volume>15</volume><fpage>1</fpage><lpage>45</lpage></element-citation></ref><ref id="B23-jcm-08-01092"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonde</surname><given-names>A.K.</given-names></name><name><surname>Tischler</surname><given-names>V.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Soltermann</surname><given-names>A.</given-names></name><name><surname>Schwendener</surname><given-names>R.A.</given-names></name></person-group><article-title>Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors</article-title><source>BMC Cancer</source><year>2012</year><volume>12</volume><elocation-id>35</elocation-id><pub-id pub-id-type="pmid">22273460</pub-id></element-citation></ref><ref id="B24-jcm-08-01092"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieto</surname><given-names>M.A.</given-names></name><name><surname>Huang</surname><given-names>R.Y.Y.J.</given-names></name><name><surname>Jackson</surname><given-names>R.A.A.</given-names></name><name><surname>Thiery</surname><given-names>J.P.P.</given-names></name></person-group><article-title>Emt: 2016</article-title><source>Cell</source><year>2016</year><volume>166</volume><fpage>21</fpage><lpage>45</lpage><?supplied-pmid 27368099?><pub-id pub-id-type="pmid">27368099</pub-id></element-citation></ref><ref id="B25-jcm-08-01092"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>A.W.</given-names></name><name><surname>Pattabiraman</surname><given-names>D.R.</given-names></name><name><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group><article-title>Emerging Biological Principles of Metastasis</article-title><source>Cell</source><year>2017</year><volume>168</volume><fpage>670</fpage><lpage>691</lpage><?supplied-pmid 28187288?><pub-id pub-id-type="pmid">28187288</pub-id></element-citation></ref><ref id="B26-jcm-08-01092"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>D.</given-names></name><name><surname>Vahdat</surname><given-names>L.T.</given-names></name><name><surname>Wong</surname><given-names>S.</given-names></name><name><surname>Chang</surname><given-names>J.C.</given-names></name><name><surname>Mittal</surname><given-names>V.</given-names></name></person-group><article-title>Microenvironmental regulation of epithelial-mesenchymal transitions in cancer</article-title><source>Cancer Res.</source><year>2012</year><volume>72</volume><fpage>4883</fpage><lpage>4889</lpage><?supplied-pmid 23002209?><pub-id pub-id-type="pmid">23002209</pub-id></element-citation></ref><ref id="B27-jcm-08-01092"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolly</surname><given-names>M.K.</given-names></name><name><surname>Boareto</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Jia</surname><given-names>D.</given-names></name><name><surname>Onuchic</surname><given-names>J.N.</given-names></name><name><surname>Levine</surname><given-names>H.</given-names></name></person-group><article-title>Implications of the hybrid epithelial/mesenchymal phenotype in metastasis</article-title><source>Front Oncol.</source><year>2015</year><volume>5</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">25667919</pub-id></element-citation></ref><ref id="B28-jcm-08-01092"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grigore</surname><given-names>A.D.</given-names></name><name><surname>Jolly</surname><given-names>M.K.</given-names></name><name><surname>Jia</surname><given-names>D.</given-names></name></person-group><article-title>Tumor Budding: The Name is EMT. Partial EMT</article-title><source>J. Clin. Med.</source><year>2016</year><volume>5</volume><fpage>1</fpage><lpage>23</lpage></element-citation></ref><ref id="B29-jcm-08-01092"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Fang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name></person-group><article-title>Expression of IL-17 with tumor budding as a prognostic marker in oral squamous cell carcinoma</article-title><source>Am. J. Transl. Res.</source><year>2019</year><volume>11</volume><fpage>1876</fpage><lpage>1883</lpage><pub-id pub-id-type="pmid">30972211</pub-id></element-citation></ref><ref id="B30-jcm-08-01092"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzo Soriano</surname><given-names>L.</given-names></name><name><surname>Ordaz Jurado</surname><given-names>G.</given-names></name><name><surname>Pontones Moreno</surname><given-names>J.L.</given-names></name><name><surname>Villarroya Castillo</surname><given-names>S.</given-names></name><name><surname>Hern&#x000e1;ndez Gir&#x000f3;n</surname><given-names>S.</given-names></name><name><surname>S&#x000e1;ez Moreno</surname><given-names>I.</given-names></name><name><surname>Ramos Soler</surname><given-names>D.</given-names></name></person-group><article-title>Tumor Budding: Prognostic Value in Muscle-Invasive Bladder Cancer</article-title><source>Urology</source><year>2019</year></element-citation></ref><ref id="B31-jcm-08-01092"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirin</surname><given-names>A.H.</given-names></name><name><surname>Sokmen</surname><given-names>S.</given-names></name><name><surname>Unlu</surname><given-names>S.M.</given-names></name><name><surname>Ellidokuz</surname><given-names>H.</given-names></name><name><surname>Sarioglu</surname><given-names>S.</given-names></name></person-group><article-title>The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy</article-title><source>Tech. Coloproctol.</source><year>2019</year><volume>23</volume><fpage>333</fpage><lpage>342</lpage><?supplied-pmid 30900039?><pub-id pub-id-type="pmid">30900039</pub-id></element-citation></ref><ref id="B32-jcm-08-01092"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekmekci</surname><given-names>S.</given-names></name><name><surname>Kucuk</surname><given-names>U.</given-names></name><name><surname>Kokkoz</surname><given-names>S.</given-names></name><name><surname>Cakir</surname><given-names>E.</given-names></name><name><surname>Gumussoy</surname><given-names>M.</given-names></name></person-group><article-title>Tumor budding in laryngeal carcinoma</article-title><source>Indian J. Pathol. Microbiol.</source><year>2019</year><volume>62</volume><fpage>7</fpage><lpage>10</lpage><?supplied-pmid 30706852?><pub-id pub-id-type="pmid">30706852</pub-id></element-citation></ref><ref id="B33-jcm-08-01092"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>R.</given-names></name><name><surname>Khurana</surname><given-names>N.</given-names></name><name><surname>Singh</surname><given-names>T.</given-names></name><name><surname>Agarwal</surname><given-names>P.N.</given-names></name></person-group><article-title>Tumor budding in infiltrating breast carcinoma: Correlation with known clinicopathological parameters and hormone receptor status</article-title><source>Indian J. Pathol. Microbiol.</source><year>2019</year><volume>62</volume><fpage>222</fpage><lpage>225</lpage><?supplied-pmid 30971544?><pub-id pub-id-type="pmid">30971544</pub-id></element-citation></ref><ref id="B34-jcm-08-01092"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogino</surname><given-names>M.</given-names></name><name><surname>Nakanishi</surname><given-names>Y.</given-names></name><name><surname>Mitsuhashi</surname><given-names>T.</given-names></name><name><surname>Hatanaka</surname><given-names>Y.</given-names></name><name><surname>Amano</surname><given-names>T.</given-names></name><name><surname>Marukawa</surname><given-names>K.</given-names></name><name><surname>Nitta</surname><given-names>T.</given-names></name><name><surname>Ueno</surname><given-names>T.</given-names></name><name><surname>Ono</surname><given-names>M.</given-names></name><name><surname>Kuwabara</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Impact of Tumour Budding Grade in 310 Patients Who Underwent Surgical Resection for Extrahepatic Cholangiocarcinoma</article-title><source>Histopathology</source><year>2019</year><volume>74</volume><fpage>861</fpage><lpage>872</lpage><?supplied-pmid 30667537?><pub-id pub-id-type="pmid">30667537</pub-id></element-citation></ref><ref id="B35-jcm-08-01092"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Jolly</surname><given-names>M.K.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Tsarfaty</surname><given-names>I.</given-names></name><name><surname>Ben-Jacob</surname><given-names>E.</given-names></name><name><surname>Onuchic</surname><given-names>J.N.</given-names></name></person-group><article-title>Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis</article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="B36-jcm-08-01092"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>S.</given-names></name><name><surname>Boekhorst</surname><given-names>V.</given-names></name><name><surname>Odenthal</surname><given-names>J.</given-names></name><name><surname>Bianchi</surname><given-names>R.</given-names></name><name><surname>van Helvert</surname><given-names>S.</given-names></name><name><surname>Ikenberg</surname><given-names>K.</given-names></name><name><surname>Ilina</surname><given-names>O.</given-names></name><name><surname>Stoma</surname><given-names>S.</given-names></name><name><surname>Xandry</surname><given-names>J.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells</article-title><source>Curr. Biol.</source><year>2017</year><volume>27</volume><fpage>392</fpage><lpage>400</lpage><?supplied-pmid 28089517?><pub-id pub-id-type="pmid">28089517</pub-id></element-citation></ref><ref id="B37-jcm-08-01092"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bockhorn</surname><given-names>M.</given-names></name><name><surname>Jain</surname><given-names>R.K.</given-names></name><name><surname>Munn</surname><given-names>L.L.</given-names></name></person-group><article-title>Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?</article-title><source>Lancet Oncol.</source><year>2007</year><volume>8</volume><fpage>444</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">17466902</pub-id></element-citation></ref><ref id="B38-jcm-08-01092"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iguchi</surname><given-names>T.</given-names></name><name><surname>Aishima</surname><given-names>S.</given-names></name><name><surname>Taketomi</surname><given-names>A.</given-names></name><name><surname>Nishihara</surname><given-names>Y.</given-names></name><name><surname>Fujita</surname><given-names>N.</given-names></name><name><surname>Sanefuji</surname><given-names>K.</given-names></name><name><surname>Maehara</surname><given-names>Y.</given-names></name><name><surname>Tsuneyoshi</surname><given-names>M.</given-names></name></person-group><article-title>Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma</article-title><source>Am. J. Surg. Pathol.</source><year>2008</year><volume>32</volume><fpage>1675</fpage><lpage>1682</lpage><?supplied-pmid 18769333?><pub-id pub-id-type="pmid">18769333</pub-id></element-citation></ref><ref id="B39-jcm-08-01092"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehes</surname><given-names>G.</given-names></name><name><surname>Witt</surname><given-names>A.</given-names></name><name><surname>Kubista</surname><given-names>E.</given-names></name><name><surname>Ambros</surname><given-names>P.F.</given-names></name></person-group><article-title>Circulating Breast Cancer Cells Are Frequently Apoptotic</article-title><source>Am. J. Pathol.</source><year>2001</year><volume>159</volume><fpage>17</fpage><lpage>20</lpage><?supplied-pmid 11438448?><pub-id pub-id-type="pmid">11438448</pub-id></element-citation></ref><ref id="B40-jcm-08-01092"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>C.J.</given-names></name><name><surname>Moreno</surname><given-names>J.G.</given-names></name><name><surname>Pienta</surname><given-names>K.J.</given-names></name><name><surname>Gross</surname><given-names>S.</given-names></name><name><surname>Repollet</surname><given-names>M.</given-names></name><name><surname>O&#x02019;Hara</surname><given-names>S.M.</given-names></name><name><surname>Russell</surname><given-names>T.</given-names></name><name><surname>Terstappen</surname><given-names>L.W.</given-names></name></person-group><article-title>Apoptosis of circulating tumor cells in prostate cancer patients</article-title><source>Cytom. Part A</source><year>2004</year><volume>62</volume><fpage>46</fpage><lpage>53</lpage></element-citation></ref><ref id="B41-jcm-08-01092"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hood</surname><given-names>J.D.</given-names></name><name><surname>Cheresh</surname><given-names>D.A.</given-names></name></person-group><article-title>Role of integrins in cell invasion and migration</article-title><source>Nat. Rev.</source><year>2002</year><volume>2</volume><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="B42-jcm-08-01092"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowe</surname><given-names>R.G.</given-names></name><name><surname>Weiss</surname><given-names>S.J.</given-names></name></person-group><article-title>Navigating ECM Barriers at the Invasive Front: The Cancer Cell&#x02014;Stroma Interface</article-title><source>Annu. Rev. Cell Dev. Biol.</source><year>2009</year><volume>25</volume><fpage>567</fpage><lpage>595</lpage><?supplied-pmid 19575644?><pub-id pub-id-type="pmid">19575644</pub-id></element-citation></ref><ref id="B43-jcm-08-01092"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sentani</surname><given-names>K.</given-names></name><name><surname>Matsuda</surname><given-names>M.</given-names></name></person-group><article-title>Clinicopathological significance of MMP-7, laminin &#x003b3;2 and EGFR expression at the invasive front of gastric carcinoma</article-title><source>Gastric Cancer</source><year>2014</year><volume>17</volume><fpage>412</fpage><lpage>422</lpage><?supplied-pmid 24048760?><pub-id pub-id-type="pmid">24048760</pub-id></element-citation></ref><ref id="B44-jcm-08-01092"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halfter</surname><given-names>W.</given-names></name><name><surname>Oertle</surname><given-names>P.</given-names></name><name><surname>Monnier</surname><given-names>C.A.</given-names></name><name><surname>Camenzind</surname><given-names>L.</given-names></name><name><surname>Reyes-Lua</surname><given-names>M.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Candiello</surname><given-names>J.</given-names></name><name><surname>Labilloy</surname><given-names>A.</given-names></name><name><surname>Balasubramani</surname><given-names>M.</given-names></name><name><surname>Henrich</surname><given-names>P.B.</given-names></name><etal/></person-group><article-title>New concepts in basement membrane biology</article-title><source>FEBS J.</source><year>2015</year><volume>282</volume><fpage>4466</fpage><lpage>4479</lpage><?supplied-pmid 26299746?><pub-id pub-id-type="pmid">26299746</pub-id></element-citation></ref><ref id="B45-jcm-08-01092"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hintermann</surname><given-names>E.</given-names></name><name><surname>Quaranta</surname><given-names>V.</given-names></name></person-group><article-title>Epithelial cell motility on laminin-5: Regulation by matrix assembly, proteolysis, integrins and erbB receptors</article-title><source>Matrix Biol.</source><year>2004</year><volume>23</volume><fpage>75</fpage><lpage>85</lpage><?supplied-pmid 15246107?><pub-id pub-id-type="pmid">15246107</pub-id></element-citation></ref><ref id="B46-jcm-08-01092"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuda</surname><given-names>R.</given-names></name><name><surname>Kijima</surname><given-names>H.</given-names></name><name><surname>Imamura</surname><given-names>N.</given-names></name><name><surname>Aruga</surname><given-names>N.</given-names></name><name><surname>Nakazato</surname><given-names>K.</given-names></name><name><surname>Oiwa</surname><given-names>K.</given-names></name><name><surname>Nakano</surname><given-names>T.</given-names></name><name><surname>Watanabe</surname><given-names>H.</given-names></name><name><surname>Ikoma</surname><given-names>Y.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Laminin-5 gamma 2 chain expression is associated with tumor cell invasiveness and prognosis of lung squamous cell carcinoma</article-title><source>Biomed. Res.</source><year>2012</year><volume>33</volume><fpage>309</fpage><lpage>317</lpage><?supplied-pmid 23124251?><pub-id pub-id-type="pmid">23124251</pub-id></element-citation></ref><ref id="B47-jcm-08-01092"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Sah</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>S.S.</given-names></name><name><surname>Radhakrishnan</surname><given-names>R.</given-names></name></person-group><article-title>Molecular changes in invasive front of oral cancer</article-title><source>J. Oral Maxillofac. Pathol.</source><year>2013</year><volume>17</volume><fpage>240</fpage><lpage>247</lpage><?supplied-pmid 24250086?><pub-id pub-id-type="pmid">24250086</pub-id></element-citation></ref><ref id="B48-jcm-08-01092"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramovs</surname><given-names>V.</given-names></name><name><surname>te Molder</surname><given-names>L.</given-names></name><name><surname>Sonnenberg</surname><given-names>A.</given-names></name></person-group><article-title>The opposing roles of laminin-binding integrins in cancer</article-title><source>Matrix Biol.</source><year>2017</year><volume>57</volume><fpage>213</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">27562932</pub-id></element-citation></ref><ref id="B49-jcm-08-01092"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>T.</given-names></name><name><surname>Wondimu</surname><given-names>Z.</given-names></name><name><surname>Oikawa</surname><given-names>Y.</given-names></name><name><surname>Gentilcore</surname><given-names>G.</given-names></name><name><surname>Kiessling</surname><given-names>R.</given-names></name><name><surname>Egyhazi Brage</surname><given-names>S.</given-names></name><name><surname>Hansson</surname><given-names>J.</given-names></name><name><surname>Patarroyo</surname><given-names>M.</given-names></name></person-group><article-title>Laminins 411 and 421 differentially promote tumor cell migration via &#x003b1;6&#x003b2;1 integrin and MCAM (CD146)</article-title><source>Matrix Biol.</source><year>2014</year><volume>38</volume><fpage>69</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">24951930</pub-id></element-citation></ref><ref id="B50-jcm-08-01092"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Fu</surname><given-names>W.</given-names></name><name><surname>Im</surname><given-names>J.H.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Santoro</surname><given-names>S.A.</given-names></name><name><surname>Iyer</surname><given-names>V.</given-names></name><name><surname>DiPersio</surname><given-names>C.M.</given-names></name><name><surname>Yu</surname><given-names>Q.C.</given-names></name><name><surname>Quaranta</surname><given-names>V.</given-names></name><name><surname>Al-Mehdi</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Tumor cell &#x003b1;3&#x003b2;1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis</article-title><source>J. Cell Biol.</source><year>2004</year><volume>164</volume><fpage>935</fpage><lpage>941</lpage><pub-id pub-id-type="pmid">15024036</pub-id></element-citation></ref><ref id="B51-jcm-08-01092"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maltseva</surname><given-names>D.V.</given-names></name><name><surname>Rodin</surname><given-names>S.A.</given-names></name></person-group><article-title>Laminins in Metastatic Cancer</article-title><source>Mol. Biol.</source><year>2018</year><volume>52</volume><fpage>350</fpage><lpage>371</lpage></element-citation></ref><ref id="B52-jcm-08-01092"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>K.</given-names></name></person-group><article-title>Laminin-5 (laminin-332): Unique biological activity and role in tumor growth and invasion</article-title><source>Cancer Sci.</source><year>2006</year><volume>97</volume><fpage>91</fpage><lpage>98</lpage><?supplied-pmid 16441418?><pub-id pub-id-type="pmid">16441418</pub-id></element-citation></ref><ref id="B53-jcm-08-01092"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>H.</given-names></name><name><surname>Kitadai</surname><given-names>Y.</given-names></name><name><surname>Yamamoto</surname><given-names>H.</given-names></name><name><surname>Oue</surname><given-names>N.</given-names></name><name><surname>Ohdan</surname><given-names>H.</given-names></name><name><surname>Yasui</surname><given-names>W.</given-names></name><name><surname>Kikuchi</surname><given-names>A.</given-names></name></person-group><article-title>Laminin &#x003b3;2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells</article-title><source>Gastroenterology</source><year>2009</year><volume>137</volume><fpage>242</fpage><lpage>252</lpage><?supplied-pmid 19582886?><pub-id pub-id-type="pmid">19582886</pub-id></element-citation></ref><ref id="B54-jcm-08-01092"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>K.-I.</given-names></name><name><surname>Kijima</surname><given-names>H.</given-names></name><name><surname>Imaizumi</surname><given-names>T.</given-names></name><name><surname>Hirabayashi</surname><given-names>K.</given-names></name><name><surname>Matsuyama</surname><given-names>M.</given-names></name><name><surname>Yazawa</surname><given-names>N.</given-names></name><name><surname>Oida</surname><given-names>Y.</given-names></name><name><surname>Tobita</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>Dowaki</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Stromal laminin-5&#x003b3;2 chain expression is associated with the wall-invasion pattern of gallbladder adenocarcinoma</article-title><source>Biomed. Res.</source><year>2009</year><volume>30</volume><fpage>53</fpage><lpage>62</lpage><?supplied-pmid 19265264?><pub-id pub-id-type="pmid">19265264</pub-id></element-citation></ref><ref id="B55-jcm-08-01092"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niki</surname><given-names>T.</given-names></name><name><surname>Kohno</surname><given-names>T.</given-names></name><name><surname>Iba</surname><given-names>S.</given-names></name><name><surname>Moriya</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>Y.</given-names></name><name><surname>Saito</surname><given-names>M.</given-names></name><name><surname>Maeshima</surname><given-names>A.</given-names></name></person-group><article-title>Frequent Co-Localization of Cox-2 and Laminin-5 &#x003b3;2 Chain at the Invasive Front of Early-Stage Lung Adenocarcinomas</article-title><source>Am. J. Pathol.</source><year>2002</year><volume>160</volume><fpage>1129</fpage><lpage>1141</lpage><?supplied-pmid 11891209?><pub-id pub-id-type="pmid">11891209</pub-id></element-citation></ref><ref id="B56-jcm-08-01092"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karamitopoulou</surname><given-names>E.</given-names></name><name><surname>Zlobec</surname><given-names>I.</given-names></name><name><surname>Panayiotides</surname><given-names>I.</given-names></name><name><surname>Patsouris</surname><given-names>E.S.</given-names></name><name><surname>Peros</surname><given-names>G.</given-names></name><name><surname>Rallis</surname><given-names>G.</given-names></name><name><surname>Lapas</surname><given-names>C.</given-names></name><name><surname>Karakitsos</surname><given-names>P.</given-names></name><name><surname>Terracciano</surname><given-names>L.M.</given-names></name><name><surname>Lugli</surname><given-names>A.</given-names></name></person-group><article-title>Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer</article-title><source>Hum. Pathol.</source><year>2011</year><volume>42</volume><fpage>1888</fpage><lpage>1896</lpage><?supplied-pmid 21664646?><pub-id pub-id-type="pmid">21664646</pub-id></element-citation></ref><ref id="B57-jcm-08-01092"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowy</surname><given-names>C.M.</given-names></name><name><surname>Oskarsson</surname><given-names>T.</given-names></name><name><surname>Lowy</surname><given-names>C.M.</given-names></name><name><surname>Oskarsson</surname><given-names>T.</given-names></name></person-group><article-title>Tenascin C in metastasis: A view from the invasive front</article-title><source>Cell Adh. Migr.</source><year>2015</year><volume>9</volume><fpage>112</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">25738825</pub-id></element-citation></ref><ref id="B58-jcm-08-01092"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Solano</surname><given-names>J.</given-names></name><name><surname>Conesa-Zamora</surname><given-names>P.</given-names></name><name><surname>Trujillo-Santos</surname><given-names>J.</given-names></name><name><surname>Torres-Moreno</surname><given-names>D.</given-names></name><name><surname>M&#x000e4;kinen</surname><given-names>M.J.</given-names></name><name><surname>P&#x000e9;rez-Guillermo</surname><given-names>M.</given-names></name></person-group><article-title>Immunohistochemical expression profile of &#x003b2;-catenin, E-cadherin, P-cadherin, laminin-5&#x003b3;2 chain, and SMAD4 in colorectal serrated adenocarcinoma</article-title><source>Hum. Pathol.</source><year>2012</year><volume>43</volume><fpage>1094</fpage><lpage>1102</lpage><pub-id pub-id-type="pmid">22209340</pub-id></element-citation></ref><ref id="B59-jcm-08-01092"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>Y.K.</given-names></name><name><surname>Kim</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>M.K.</given-names></name><name><surname>Choi</surname><given-names>J.E.</given-names></name><name><surname>Kang</surname><given-names>S.H.</given-names></name><name><surname>Lee</surname><given-names>S.J.</given-names></name></person-group><article-title>Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer</article-title><source>Hum. Pathol.</source><year>2013</year><volume>44</volume><fpage>2028</fpage><lpage>2037</lpage><pub-id pub-id-type="pmid">23684510</pub-id></element-citation></ref><ref id="B60-jcm-08-01092"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopal</surname><given-names>S.</given-names></name><name><surname>Veracini</surname><given-names>L.</given-names></name><name><surname>Grall</surname><given-names>D.</given-names></name><name><surname>Butori</surname><given-names>C.</given-names></name><name><surname>Schaub</surname><given-names>S.</given-names></name><name><surname>Audebert</surname><given-names>S.</given-names></name><name><surname>Camoin</surname><given-names>L.</given-names></name><name><surname>Baudelet</surname><given-names>E.</given-names></name><name><surname>Adwanska</surname><given-names>A.</given-names></name><name><surname>Beghelli-De La Forest Divonne</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Fibronectin-guided migration of carcinoma collectives</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>14105</fpage><pub-id pub-id-type="pmid">28102238</pub-id></element-citation></ref><ref id="B61-jcm-08-01092"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Oliveira Ramos</surname><given-names>G.</given-names></name><name><surname>Bernardi</surname><given-names>L.</given-names></name><name><surname>Lauxen</surname><given-names>I.</given-names></name><name><surname>Filho</surname><given-names>M.S.A.</given-names></name><name><surname>Horwitz</surname><given-names>A.R.</given-names></name><name><surname>Lamers</surname><given-names>M.L.</given-names></name></person-group><article-title>Fibronectin modulates cell adhesion and signaling to promote single cell migration of highly invasive oral squamous cell carcinoma</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><fpage>1</fpage><lpage>18</lpage></element-citation></ref><ref id="B62-jcm-08-01092"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aishima</surname><given-names>S.</given-names></name><name><surname>Taguchi</surname><given-names>K.</given-names></name><name><surname>Terashi</surname><given-names>T.</given-names></name><name><surname>Matsuura</surname><given-names>S.</given-names></name><name><surname>Shimada</surname><given-names>M.</given-names></name><name><surname>Tsuneyoshi</surname><given-names>M.</given-names></name></person-group><article-title>Tenascin Expression at the Invasive Front Is Associated with Poor Prognosis in Intrahepatic Cholangiocarcinoma</article-title><source>Mod. Pathol.</source><year>2003</year><volume>16</volume><fpage>1019</fpage><lpage>1027</lpage><?supplied-pmid 14559985?><pub-id pub-id-type="pmid">14559985</pub-id></element-citation></ref><ref id="B63-jcm-08-01092"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurzu</surname><given-names>S.</given-names></name></person-group><article-title>Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update</article-title><source>World J. Clin. Cases</source><year>2015</year><volume>3</volume><fpage>393</fpage><lpage>404</lpage><?supplied-pmid 25984514?><pub-id pub-id-type="pmid">25984514</pub-id></element-citation></ref><ref id="B64-jcm-08-01092"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christofori</surname><given-names>G.</given-names></name></person-group><article-title>New signals from the invasive front</article-title><source>Nature</source><year>2006</year><volume>441</volume><fpage>444</fpage><lpage>450</lpage><?supplied-pmid 16724056?><pub-id pub-id-type="pmid">16724056</pub-id></element-citation></ref><ref id="B65-jcm-08-01092"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>J.</given-names></name><name><surname>Ogura</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Inuzuka</surname><given-names>H.</given-names></name></person-group><article-title>Degradation of the Transcription Factor Twist, an Oncoprotein that Promotes Cancer Metastasis</article-title><source>Discov Med.</source><year>2013</year><volume>15</volume><fpage>7</fpage><lpage>15</lpage><?supplied-pmid 23375009?><pub-id pub-id-type="pmid">23375009</pub-id></element-citation></ref><ref id="B66-jcm-08-01092"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krakhmal</surname><given-names>N.V.</given-names></name><name><surname>Zavyalova</surname><given-names>M.V.</given-names></name><name><surname>Perelmuter</surname><given-names>V.M.</given-names></name><name><surname>Vtorushin</surname><given-names>S.V.</given-names></name><name><surname>Slonimskaya</surname><given-names>E.M.</given-names></name><name><surname>Denisov</surname><given-names>E.V.</given-names></name></person-group><article-title>Heterogeneous expression of markers associated with invasive breast cancer (in Russ)</article-title><source>Sib. J. Oncol.</source><year>2016</year><volume>15</volume><fpage>56</fpage><lpage>61</lpage></element-citation></ref><ref id="B67-jcm-08-01092"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brabletz</surname><given-names>T.</given-names></name><name><surname>Kalluri</surname><given-names>R.</given-names></name><name><surname>Nieto</surname><given-names>M.A.</given-names></name><name><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group><article-title>EMT in cancer</article-title><source>Nat. Rev. Cancer</source><year>2018</year><volume>18</volume><fpage>128</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">29326430</pub-id></element-citation></ref><ref id="B68-jcm-08-01092"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brabletz</surname><given-names>T.</given-names></name><name><surname>Jung</surname><given-names>A.</given-names></name><name><surname>Reu</surname><given-names>S.</given-names></name><name><surname>Porzner</surname><given-names>M.</given-names></name><name><surname>Hlubek</surname><given-names>F.</given-names></name><name><surname>Kunz-Schughart</surname><given-names>L.A.</given-names></name><name><surname>Knuechel</surname><given-names>R.</given-names></name><name><surname>Kirchner</surname><given-names>T.</given-names></name></person-group><article-title>Variable &#x003b2;-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment</article-title><source>Proc. Natl. Acad. Sci.</source><year>2002</year><volume>98</volume><fpage>10356</fpage><lpage>10361</lpage></element-citation></ref><ref id="B69-jcm-08-01092"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>C.H.</given-names></name><name><surname>Morais</surname><given-names>M.O.</given-names></name><name><surname>Martins</surname><given-names>A.F.L.</given-names></name><name><surname>Soares</surname><given-names>M.Q.S.</given-names></name><name><surname>de C.G. Alencar</surname><given-names>R.</given-names></name><name><surname>Batista</surname><given-names>A.C.</given-names></name><name><surname>Leles</surname><given-names>C.R.</given-names></name><name><surname>Mendon&#x000e7;a</surname><given-names>E.F.</given-names></name></person-group><article-title>Expression of adhesion proteins (E-cadherin and &#x003b2;-catenin) and cell proliferation (Ki-67) at the invasive tumor front in conventional oral squamous cell and basaloid squamous cell carcinomas</article-title><source>Arch. Oral Biol.</source><year>2016</year><volume>61</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">26476747</pub-id></element-citation></ref><ref id="B70-jcm-08-01092"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>H.</given-names></name><name><surname>Masuda</surname><given-names>N.</given-names></name><name><surname>Shimura</surname><given-names>T.</given-names></name><name><surname>Araki</surname><given-names>K.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Tsutsumi</surname><given-names>S.</given-names></name><name><surname>Asao</surname><given-names>T.</given-names></name><name><surname>Kuwano</surname><given-names>H.</given-names></name></person-group><article-title>Nuclear &#x003b2;-Catenin Expression at the Invasive Front and in the Vessels Predicts Liver Metastasis in Colorectal Carcinoma</article-title><source>Anticancer Res.</source><year>2008</year><volume>28</volume><fpage>1821</fpage><lpage>1830</lpage><pub-id pub-id-type="pmid">18630466</pub-id></element-citation></ref><ref id="B71-jcm-08-01092"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Cheng</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Hu</surname><given-names>S.</given-names></name></person-group><article-title>Prognostic value of nuclear &#x003b2;-catenin overexpression at invasive front in colorectal cancer for synchronous liver metastasis</article-title><source>Ann. Surg. Oncol.</source><year>2011</year><volume>18</volume><fpage>1553</fpage><lpage>1559</lpage><?supplied-pmid 21207157?><pub-id pub-id-type="pmid">21207157</pub-id></element-citation></ref><ref id="B72-jcm-08-01092"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamir</surname><given-names>E.R.</given-names></name><name><surname>Ewald</surname><given-names>A.J.</given-names></name></person-group><article-title>Adhesion in mammary development: Novel roles for E-cadherin in individual and collective cell migration</article-title><source>Curr. Top. Dev. Biol.</source><year>2015</year><volume>112</volume><fpage>353</fpage><lpage>382</lpage><?supplied-pmid 25733146?><pub-id pub-id-type="pmid">25733146</pub-id></element-citation></ref><ref id="B73-jcm-08-01092"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>G.Y.</given-names></name><name><surname>Guo</surname><given-names>S.</given-names></name><name><surname>Dong</surname><given-names>C.Y.</given-names></name><name><surname>Wang</surname><given-names>X.Q.</given-names></name><name><surname>Hu</surname><given-names>B.Y.</given-names></name><name><surname>Liu</surname><given-names>Y.F.</given-names></name><name><surname>Chen</surname><given-names>Y.W.</given-names></name><name><surname>Niu</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>J.H.</given-names></name></person-group><article-title>Integrin &#x003b1;v&#x003b2;6 sustains and promotes tumor invasive growth in colon cancer progression</article-title><source>World J. Gastroenterol.</source><year>2015</year><volume>21</volume><fpage>7457</fpage><lpage>7467</lpage><?supplied-pmid 26139991?><pub-id pub-id-type="pmid">26139991</pub-id></element-citation></ref><ref id="B74-jcm-08-01092"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>R.L.</given-names></name><name><surname>West</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Weiss</surname><given-names>H.L.</given-names></name><name><surname>Gal</surname><given-names>T.</given-names></name><name><surname>Durbin</surname><given-names>E.B.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>K.L.</given-names></name></person-group><article-title>Elevated integrin &#x003b1;6&#x003b2;4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer</article-title><source>Hum. Pathol.</source><year>2016</year><volume>54</volume><fpage>174</fpage><lpage>183</lpage><?supplied-pmid 27107458?><pub-id pub-id-type="pmid">27107458</pub-id></element-citation></ref><ref id="B75-jcm-08-01092"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albelda</surname><given-names>S.M.</given-names></name><name><surname>Mette</surname><given-names>S.A.</given-names></name><name><surname>Elder</surname><given-names>D.E.</given-names></name><name><surname>Stewart</surname><given-names>R.M.</given-names></name><name><surname>Damjanovich</surname><given-names>L.</given-names></name><name><surname>Herlyn</surname><given-names>M.</given-names></name><name><surname>Buck</surname><given-names>C.A.</given-names></name></person-group><article-title>Integrin Distribution in Malignant Melanoma: Association of the &#x003b2;3 Subunit with Tumor Progression</article-title><source>Cancer Res.</source><year>1990</year><volume>50</volume><fpage>6757</fpage><lpage>6764</lpage><?supplied-pmid 2208139?><pub-id pub-id-type="pmid">2208139</pub-id></element-citation></ref><ref id="B76-jcm-08-01092"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koopman Van Aarsen</surname><given-names>L.A.</given-names></name><name><surname>Leone</surname><given-names>D.R.</given-names></name><name><surname>Ho</surname><given-names>S.</given-names></name><name><surname>Dolinski</surname><given-names>B.M.</given-names></name><name><surname>McCoon</surname><given-names>P.E.</given-names></name><name><surname>LePage</surname><given-names>D.J.</given-names></name><name><surname>Kelly</surname><given-names>R.</given-names></name><name><surname>Heaney</surname><given-names>G.</given-names></name><name><surname>Rayhorn</surname><given-names>P.</given-names></name><name><surname>Reid</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Antibody-mediated blockade of integrin &#x003b1;v&#x003b2;6 inhibits tumor progression in vivo by a transforming growth factor-&#x003b2;-regulated mechanism</article-title><source>Cancer Res.</source><year>2008</year><volume>68</volume><fpage>561</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">18199553</pub-id></element-citation></ref><ref id="B77-jcm-08-01092"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>F.C.</given-names></name><name><surname>Chen</surname><given-names>H.Y.</given-names></name><name><surname>Kuo</surname><given-names>C.C.</given-names></name><name><surname>Sytwu</surname><given-names>H.K.</given-names></name></person-group><article-title>Role of galectins in tumors and in clinical immunotherapy</article-title><source>Int. J. Mol. Sci.</source><year>2018</year><volume>19</volume><fpage>430</fpage></element-citation></ref><ref id="B78-jcm-08-01092"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>O.</given-names></name></person-group><article-title>Hynes. Integrins: Bidirectional, Allosteric Signaling Machines</article-title><source>Cell</source><year>2002</year><volume>110</volume><fpage>673</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">12297042</pub-id></element-citation></ref><ref id="B79-jcm-08-01092"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>M.-H.</given-names></name><name><surname>Hong</surname><given-names>H.-C.</given-names></name><name><surname>Cheng</surname><given-names>H.-W.</given-names></name><name><surname>Pan</surname><given-names>S.-H.</given-names></name><name><surname>Liang</surname><given-names>Y.-R.</given-names></name><name><surname>Hong</surname><given-names>T.-M.</given-names></name><name><surname>Chiang</surname><given-names>W.-F.</given-names></name><name><surname>Wong</surname><given-names>T.-Y.</given-names></name><name><surname>Shieh</surname><given-names>D.-B.</given-names></name><name><surname>Shiau</surname><given-names>A.-L.</given-names></name><etal/></person-group><article-title>Galectin-1-Mediated Tumor Invasion and Metastasis, Up-Regulated Matrix Metalloproteinase Expression, and Reorganized Actin Cytoskeletons</article-title><source>Mol. Cancer Res.</source><year>2009</year><volume>7</volume><fpage>311</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">19276182</pub-id></element-citation></ref><ref id="B80-jcm-08-01092"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toussaint</surname><given-names>L.G.</given-names></name><name><surname>Nilson</surname><given-names>A.E.</given-names></name><name><surname>Goble</surname><given-names>J.M.</given-names></name><name><surname>Ballman</surname><given-names>K.V.</given-names></name><name><surname>James</surname><given-names>C.D.</given-names></name><name><surname>Lefranc</surname><given-names>F.</given-names></name><name><surname>Kiss</surname><given-names>R.</given-names></name><name><surname>Uhm</surname><given-names>J.H.</given-names></name></person-group><article-title>Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion</article-title><source>Mol. Cancer</source><year>2012</year><volume>11</volume><fpage>32</fpage><?supplied-pmid 22583806?><pub-id pub-id-type="pmid">22583806</pub-id></element-citation></ref><ref id="B81-jcm-08-01092"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavert</surname><given-names>N.</given-names></name><name><surname>Conacci-sorrell</surname><given-names>M.</given-names></name><name><surname>Gast</surname><given-names>D.</given-names></name><name><surname>Schneider</surname><given-names>A.</given-names></name><name><surname>Altevogt</surname><given-names>P.</given-names></name><name><surname>Brabletz</surname><given-names>T.</given-names></name><name><surname>Ben-Ze&#x02019;ev</surname><given-names>A.</given-names></name></person-group><article-title>L1, a novel target of &#x003b2;-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers</article-title><source>J. Cell Biol.</source><year>2005</year><volume>168</volume><fpage>633</fpage><lpage>642</lpage><?supplied-pmid 15716380?><pub-id pub-id-type="pmid">15716380</pub-id></element-citation></ref><ref id="B82-jcm-08-01092"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsutsumi</surname><given-names>S.</given-names></name><name><surname>Morohashi</surname><given-names>S.</given-names></name><name><surname>Kudo</surname><given-names>Y.</given-names></name><name><surname>Akasaka</surname><given-names>H.</given-names></name><name><surname>Ogasawara</surname><given-names>H.</given-names></name><name><surname>Ono</surname><given-names>M.</given-names></name><name><surname>Takasugi</surname><given-names>K.</given-names></name><name><surname>Ishido</surname><given-names>K.</given-names></name><name><surname>Hakamada</surname><given-names>K.</given-names></name><name><surname>Kijima</surname><given-names>H.</given-names></name></person-group><article-title>L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma</article-title><source>J. Surg. Oncol.</source><year>2011</year><volume>103</volume><fpage>669</fpage><lpage>673</lpage><?supplied-pmid 21360711?><pub-id pub-id-type="pmid">21360711</pub-id></element-citation></ref><ref id="B83-jcm-08-01092"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altevogt</surname><given-names>P.</given-names></name><name><surname>Doberstein</surname><given-names>K.</given-names></name><name><surname>Fogel</surname><given-names>M.</given-names></name></person-group><article-title>L1CAM in human cancer</article-title><source>Int. J. Cancer</source><year>2016</year><volume>138</volume><fpage>1565</fpage><lpage>1576</lpage><pub-id pub-id-type="pmid">26111503</pub-id></element-citation></ref><ref id="B84-jcm-08-01092"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Z.</given-names></name><name><surname>Stack</surname><given-names>M.S.</given-names></name></person-group><article-title>Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity</article-title><source>Biochem. J.</source><year>2007</year><volume>407</volume><fpage>153</fpage><lpage>159</lpage><?supplied-pmid 17880283?><pub-id pub-id-type="pmid">17880283</pub-id></element-citation></ref><ref id="B85-jcm-08-01092"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f8;mer</surname><given-names>J.</given-names></name><name><surname>Pyke</surname><given-names>C.</given-names></name><name><surname>Lund</surname><given-names>L.R.</given-names></name><name><surname>Ralfki&#x000e6;r</surname><given-names>E.</given-names></name><name><surname>Dan&#x000f8;</surname><given-names>K.</given-names></name></person-group><article-title>Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin</article-title><source>J. Invest. Dermatol.</source><year>2001</year><volume>116</volume><fpage>353</fpage><lpage>358</lpage><?supplied-pmid 11231307?><pub-id pub-id-type="pmid">11231307</pub-id></element-citation></ref><ref id="B86-jcm-08-01092"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmood</surname><given-names>N.</given-names></name><name><surname>Mihalcioiu</surname><given-names>C.</given-names></name><name><surname>Rabbani</surname><given-names>S.A.</given-names></name></person-group><article-title>Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications</article-title><source>Front. Oncol.</source><year>2018</year><volume>8</volume><fpage>24</fpage><?supplied-pmid 29484286?><pub-id pub-id-type="pmid">29484286</pub-id></element-citation></ref><ref id="B87-jcm-08-01092"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessenbrock</surname><given-names>K.</given-names></name><name><surname>Plaks</surname><given-names>V.</given-names></name><name><surname>Werb</surname><given-names>Z.</given-names></name></person-group><article-title>Matrix Metalloproteinases: Regulators of the Tumor Microenvironment</article-title><source>Cell</source><year>2010</year><volume>141</volume><fpage>52</fpage><lpage>67</lpage><?supplied-pmid 20371345?><pub-id pub-id-type="pmid">20371345</pub-id></element-citation></ref><ref id="B88-jcm-08-01092"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ondruschka</surname><given-names>C.</given-names></name><name><surname>Buhtz</surname><given-names>P.</given-names></name><name><surname>Motsch</surname><given-names>C.</given-names></name><name><surname>Freigang</surname><given-names>B.</given-names></name><name><surname>Schneider-Stock</surname><given-names>R.</given-names></name><name><surname>Roessner</surname><given-names>A.</given-names></name><name><surname>Boltze</surname><given-names>C.</given-names></name></person-group><article-title>Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas</article-title><source>Pathol. Res. Pract.</source><year>2002</year><volume>198</volume><fpage>509</fpage><lpage>515</lpage><?supplied-pmid 12389993?><pub-id pub-id-type="pmid">12389993</pub-id></element-citation></ref><ref id="B89-jcm-08-01092"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ntayi</surname><given-names>C.</given-names></name><name><surname>Labrousse</surname><given-names>A.L.</given-names></name><name><surname>Debret</surname><given-names>R.</given-names></name><name><surname>Birembaut</surname><given-names>P.</given-names></name><name><surname>Bellon</surname><given-names>G.</given-names></name><name><surname>Antonicelli</surname><given-names>F.</given-names></name><name><surname>Hornebeck</surname><given-names>W.</given-names></name><name><surname>Bernard</surname><given-names>P.</given-names></name></person-group><article-title>Elastin-Derived Peptides Upregulate Matrix Metalloproteinase-2-ediated Melanoma Cell Invasion Through Elastin-Binding Protein</article-title><source>J. Invest. Dermatol.</source><year>2004</year><volume>122</volume><fpage>256</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">15009703</pub-id></element-citation></ref><ref id="B90-jcm-08-01092"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.P.</given-names></name><name><surname>Kawauchi</surname><given-names>S.</given-names></name><name><surname>Oga</surname><given-names>A.</given-names></name><name><surname>Tsushimi</surname><given-names>K.</given-names></name><name><surname>Tsushimi</surname><given-names>M.</given-names></name></person-group><article-title>Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma</article-title><source>Jpn. J. Cancer Res.</source><year>2002</year><volume>7</volume><fpage>291</fpage><lpage>295</lpage></element-citation></ref><ref id="B91-jcm-08-01092"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitoh</surname><given-names>T.</given-names></name><name><surname>Yanai</surname><given-names>H.</given-names></name><name><surname>Saitoh</surname><given-names>Y.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Matsubara</surname><given-names>Y.</given-names></name><name><surname>Kitoh</surname><given-names>H.</given-names></name><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Okita</surname><given-names>K.</given-names></name></person-group><article-title>Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer</article-title><source>J. Gastroenterol.</source><year>2004</year><volume>39</volume><fpage>434</fpage><lpage>440</lpage><?supplied-pmid 15175941?><pub-id pub-id-type="pmid">15175941</pub-id></element-citation></ref><ref id="B92-jcm-08-01092"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>Y.</given-names></name><name><surname>Yamamoto</surname><given-names>H.</given-names></name><name><surname>Itoh</surname><given-names>F.</given-names></name><name><surname>Hinoda</surname><given-names>Y.</given-names></name><name><surname>Okada</surname><given-names>Y.</given-names></name><name><surname>Imai</surname><given-names>K.</given-names></name></person-group><article-title>Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers</article-title><source>Gut</source><year>1999</year><volume>45</volume><fpage>252</fpage><lpage>258</lpage><?supplied-pmid 10403738?><pub-id pub-id-type="pmid">10403738</pub-id></element-citation></ref><ref id="B93-jcm-08-01092"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Planagum&#x000e0;</surname><given-names>J.</given-names></name><name><surname>Liljestr&#x000f6;m</surname><given-names>M.</given-names></name><name><surname>Alameda</surname><given-names>F.</given-names></name><name><surname>B&#x000fc;tzow</surname><given-names>R.</given-names></name><name><surname>Virtanen</surname><given-names>I.</given-names></name><name><surname>Revent&#x000f3;s</surname><given-names>J.</given-names></name><name><surname>Hukkanen</surname><given-names>M.</given-names></name></person-group><article-title>Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1 / AML1 and ETV5 / ERM at the invasive front of endometrial and ovarian carcinoma</article-title><source>Hum. Pathol.</source><year>2011</year><volume>42</volume><fpage>57</fpage><lpage>67</lpage><?supplied-pmid 20970160?><pub-id pub-id-type="pmid">20970160</pub-id></element-citation></ref><ref id="B94-jcm-08-01092"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterz</surname><given-names>C.M.</given-names></name><name><surname>Kulle</surname><given-names>C.</given-names></name><name><surname>Dakic</surname><given-names>B.</given-names></name><name><surname>Makarova</surname><given-names>G.</given-names></name><name><surname>B&#x000f6;ttcher</surname><given-names>M.C.</given-names></name><name><surname>Bette</surname><given-names>M.</given-names></name><name><surname>Werner</surname><given-names>J.A.</given-names></name><name><surname>Mandic</surname><given-names>R.</given-names></name></person-group><article-title>A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9</article-title><source>Oral Oncol.</source><year>2010</year><volume>46</volume><fpage>116</fpage><lpage>122</lpage><?supplied-pmid 20036607?><pub-id pub-id-type="pmid">20036607</pub-id></element-citation></ref><ref id="B95-jcm-08-01092"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Hao</surname><given-names>F.</given-names></name><name><surname>Qiu</surname><given-names>X.</given-names></name><name><surname>Stoecker</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>E.</given-names></name></person-group><article-title>Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells</article-title><source>Tumour Biol.</source><year>2012</year><volume>33</volume><fpage>1493</fpage><lpage>1504</lpage><?supplied-pmid 22528947?><pub-id pub-id-type="pmid">22528947</pub-id></element-citation></ref><ref id="B96-jcm-08-01092"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>K.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Jin</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Yu</surname><given-names>B.</given-names></name></person-group><article-title>Prognostic Value of Ezrin in Various Cancers: A Systematic Review and Updated Meta-analysis</article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="B97-jcm-08-01092"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwaya</surname><given-names>K.</given-names></name><name><surname>Norio</surname><given-names>K.</given-names></name><name><surname>Mukai</surname><given-names>K.</given-names></name></person-group><article-title>Coexpression of Arp2 and WAVE2 predicts poor outcome in invasive breast carcinoma</article-title><source>Mod. Pathol.</source><year>2007</year><volume>20</volume><fpage>339</fpage><lpage>343</lpage><?supplied-pmid 17277766?><pub-id pub-id-type="pmid">17277766</pub-id></element-citation></ref><ref id="B98-jcm-08-01092"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosio</surname><given-names>P.E.</given-names></name><name><surname>Rosa</surname><given-names>E.F.</given-names></name><name><surname>Aparecida</surname><given-names>M.</given-names></name><name><surname>Domingues</surname><given-names>C.</given-names></name><name><surname>Andr&#x000e9;</surname><given-names>R.</given-names></name><name><surname>Villacis</surname><given-names>R.</given-names></name><name><surname>Coudry</surname><given-names>R.D.A.</given-names></name><name><surname>Tagliarini</surname><given-names>J.V.</given-names></name><name><surname>Soares</surname><given-names>F.A.</given-names></name></person-group><article-title>Cortactin is associated with perineural invasion in the deep invasive front area of laryngeal carcinomas</article-title><source>Hum. Pathol.</source><year>2011</year><volume>42</volume><fpage>1221</fpage><lpage>1229</lpage><?supplied-pmid 21419472?><pub-id pub-id-type="pmid">21419472</pub-id></element-citation></ref><ref id="B99-jcm-08-01092"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>S.I.</given-names></name><name><surname>Yanamoto</surname><given-names>S.</given-names></name><name><surname>Kawasaki</surname><given-names>G.</given-names></name><name><surname>Mizuno</surname><given-names>A.</given-names></name><name><surname>Nemoto</surname><given-names>T.K.</given-names></name></person-group><article-title>Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma</article-title><source>Pathol. Oncol. Res.</source><year>2010</year><volume>16</volume><fpage>523</fpage><lpage>531</lpage><?supplied-pmid 20069395?><pub-id pub-id-type="pmid">20069395</pub-id></element-citation></ref><ref id="B100-jcm-08-01092"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyoda</surname><given-names>A.</given-names></name><name><surname>Yokota</surname><given-names>A.Y.A.</given-names></name><name><surname>Saito</surname><given-names>T.</given-names></name><name><surname>Kawana</surname><given-names>H.</given-names></name></person-group><article-title>Overexpression of human ortholog of mammalian enabled (hMena) is associated with the expression of mutant p53 protein in human breast cancers</article-title><source>Int. J. Oncol.</source><year>2011</year><volume>38</volume><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">21109929</pub-id></element-citation></ref><ref id="B101-jcm-08-01092"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vignjevic</surname><given-names>D.</given-names></name><name><surname>Schoumacher</surname><given-names>M.</given-names></name><name><surname>Gavert</surname><given-names>N.</given-names></name><name><surname>Janssen</surname><given-names>K.</given-names></name><name><surname>Jih</surname><given-names>G.</given-names></name><name><surname>Lae</surname><given-names>M.</given-names></name><name><surname>Louvard</surname><given-names>D.</given-names></name><name><surname>Ben-ze</surname><given-names>A.</given-names></name><name><surname>Robine</surname><given-names>S.</given-names></name></person-group><article-title>Fascin, a Novel Target of &#x003b2;-Catenin-TCF Signaling, Is Expressed at the Invasive Front of Human Colon Cancer</article-title><source>Cancer Res.</source><year>2007</year><volume>67</volume><fpage>6844</fpage><lpage>6854</lpage><?supplied-pmid 17638895?><pub-id pub-id-type="pmid">17638895</pub-id></element-citation></ref><ref id="B102-jcm-08-01092"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Won</surname><given-names>K.Y.</given-names></name><name><surname>Kim</surname><given-names>G.Y.</given-names></name><name><surname>Lim</surname><given-names>S.J.</given-names></name><name><surname>Park</surname><given-names>Y.K.</given-names></name><name><surname>Kim</surname><given-names>Y.W.</given-names></name></person-group><article-title>Prognostic significance of fascin expression in extrahepatic bile duct carcinomas</article-title><source>Pathol. Res. Pract.</source><year>2009</year><volume>205</volume><fpage>742</fpage><lpage>748</lpage><?supplied-pmid 19556073?><pub-id pub-id-type="pmid">19556073</pub-id></element-citation></ref><ref id="B103-jcm-08-01092"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>C.J.R.</given-names></name><name><surname>Crook</surname><given-names>M.</given-names></name><name><surname>Loi</surname><given-names>S.</given-names></name></person-group><article-title>Fascin expression in endocervical neoplasia: Correlation with tumour morphology and growth pattern</article-title><source>J. Clin. Pathol.</source><year>2012</year><volume>65</volume><fpage>213</fpage><lpage>217</lpage><?supplied-pmid 22128198?><pub-id pub-id-type="pmid">22128198</pub-id></element-citation></ref><ref id="B104-jcm-08-01092"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>C.J.R.</given-names></name><name><surname>Crook</surname><given-names>M.L.</given-names></name></person-group><article-title>Fascin expression in undifferentiated and dedifferentiated endometrial carcinoma</article-title><source>Hum. Pathol.</source><year>2015</year><volume>46</volume><fpage>1514</fpage><lpage>1520</lpage><?supplied-pmid 26239622?><pub-id pub-id-type="pmid">26239622</pub-id></element-citation></ref><ref id="B105-jcm-08-01092"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurokawa</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Matsumoto</surname><given-names>S.</given-names></name><name><surname>Yamashita</surname><given-names>Y.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Tomoyose</surname><given-names>T.</given-names></name><name><surname>Takano</surname><given-names>H.</given-names></name><name><surname>Funaki</surname><given-names>K.</given-names></name><name><surname>Fukuyama</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>T.</given-names></name><etal/></person-group><article-title>The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma</article-title><source>J. Oral Pathol. Med.</source><year>2005</year><volume>34</volume><fpage>602</fpage><lpage>607</lpage><?supplied-pmid 16202080?><pub-id pub-id-type="pmid">16202080</pub-id></element-citation></ref><ref id="B106-jcm-08-01092"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horre</surname><given-names>N.</given-names></name><name><surname>Van Diest</surname><given-names>P.J.</given-names></name><name><surname>Sie-Go</surname><given-names>D.M.</given-names></name><name><surname>Heintz</surname><given-names>A.P.</given-names></name></person-group><article-title>The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators</article-title><source>Hum. Pathol.</source><year>2007</year><volume>38</volume><fpage>1232</fpage><lpage>1238</lpage><pub-id pub-id-type="pmid">17490724</pub-id></element-citation></ref><ref id="B107-jcm-08-01092"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group><article-title>New Insight into Ki67 Expression at the Invasive Front in Breast Cancer</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="B108-jcm-08-01092"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubio</surname><given-names>C.A.</given-names></name></person-group><article-title>Further studies on the arrest of cell proliferation in tumor cells at the invading front of colonic adenocarcinoma</article-title><source>J. Gastroenterol. Hepatol.</source><year>2007</year><volume>22</volume><fpage>1877</fpage><lpage>1881</lpage><pub-id pub-id-type="pmid">17914963</pub-id></element-citation></ref><ref id="B109-jcm-08-01092"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>Y.</given-names></name><name><surname>Ishiwata</surname><given-names>T.</given-names></name><name><surname>Yamahatsu</surname><given-names>K.</given-names></name><name><surname>Kawahara</surname><given-names>K.</given-names></name></person-group><article-title>Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: A potential therapeutic target in colorectal cancer</article-title><source>Cancer Lett.</source><year>2011</year><volume>309</volume><fpage>209</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">21745712</pub-id></element-citation></ref><ref id="B110-jcm-08-01092"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawase</surname><given-names>R.</given-names></name><name><surname>Ishiwata</surname><given-names>T.</given-names></name><name><surname>Matsuda</surname><given-names>Y.</given-names></name><name><surname>Onda</surname><given-names>M.</given-names></name><name><surname>Kudo</surname><given-names>M.</given-names></name><name><surname>Takeshita</surname><given-names>T.</given-names></name><name><surname>Naito</surname><given-names>Z.</given-names></name></person-group><article-title>Expression of fibroblast growth factor receptor 2 IIIc in human uterine cervical intraepithelial neoplasia and cervical cancer</article-title><source>Int. J. Oncol.</source><year>2010</year><volume>38</volume><fpage>257</fpage><lpage>266</lpage></element-citation></ref><ref id="B111-jcm-08-01092"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>N.</given-names></name><name><surname>Grose</surname><given-names>R.</given-names></name></person-group><article-title>Fibroblast growth factor signalling: From development to cancer</article-title><source>Nat. Rev. Cancer</source><year>2010</year><volume>10</volume><fpage>116</fpage><lpage>129</lpage><?supplied-pmid 20094046?><pub-id pub-id-type="pmid">20094046</pub-id></element-citation></ref><ref id="B112-jcm-08-01092"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>S.</given-names></name><name><surname>Ganguly</surname><given-names>K.K.</given-names></name><name><surname>Chatterjee</surname><given-names>A.</given-names></name></person-group><article-title>Extracellular matrix protein fibronectin induces matrix metalloproteinases in human prostate adenocarcinoma cells PC-3</article-title><source>Cell Commun. Adhes.</source><year>2013</year><volume>20</volume><fpage>105</fpage><lpage>114</lpage><?supplied-pmid 24047237?><pub-id pub-id-type="pmid">24047237</pub-id></element-citation></ref><ref id="B113-jcm-08-01092"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.P.</given-names></name><name><surname>Hielscher</surname><given-names>A.</given-names></name></person-group><article-title>Fibronectin: How its aberrant expression in tumors may improve therapeutic targeting</article-title><source>J. Cancer</source><year>2017</year><volume>8</volume><fpage>674</fpage><lpage>682</lpage><?supplied-pmid 28367247?><pub-id pub-id-type="pmid">28367247</pub-id></element-citation></ref><ref id="B114-jcm-08-01092"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Carstens</surname><given-names>J.L.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Scheible</surname><given-names>M.</given-names></name><name><surname>Kaye</surname><given-names>J.</given-names></name><name><surname>Sugimoto</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Lebleu</surname><given-names>V.S.</given-names></name><name><surname>Kalluri</surname><given-names>R.</given-names></name><name><surname>Biology</surname><given-names>C.</given-names></name></person-group><article-title>EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer</article-title><source>Nature</source><year>2016</year><volume>527</volume><fpage>525</fpage><lpage>530</lpage></element-citation></ref><ref id="B115-jcm-08-01092"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolly</surname><given-names>M.K.</given-names></name><name><surname>Ware</surname><given-names>K.E.</given-names></name><name><surname>Gilja</surname><given-names>S.</given-names></name><name><surname>Somarelli</surname><given-names>J.A.</given-names></name><name><surname>Levine</surname><given-names>H.</given-names></name></person-group><article-title>EMT and MET: necessary or permissive for metastasis?</article-title><source>Mol. Oncol.</source><year>2017</year><volume>11</volume><fpage>755</fpage><lpage>769</lpage><?supplied-pmid 28548345?><pub-id pub-id-type="pmid">28548345</pub-id></element-citation></ref><ref id="B116-jcm-08-01092"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savagner</surname><given-names>P.</given-names></name></person-group><article-title>Epithelial-mesenchymal transitions: From cell plasticity to concept elasticity</article-title><source>Curr. Top Dev. Biol.</source><year>2015</year><volume>112</volume><fpage>273</fpage><lpage>300</lpage><?supplied-pmid 25733143?><pub-id pub-id-type="pmid">25733143</pub-id></element-citation></ref><ref id="B117-jcm-08-01092"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamir</surname><given-names>E.R.</given-names></name><name><surname>Pappalardo</surname><given-names>E.</given-names></name><name><surname>Jorgens</surname><given-names>D.M.</given-names></name><name><surname>Coutinho</surname><given-names>K.</given-names></name><name><surname>Tsai</surname><given-names>W.T.</given-names></name><name><surname>Aziz</surname><given-names>K.</given-names></name><name><surname>Auer</surname><given-names>M.</given-names></name><name><surname>Tran</surname><given-names>P.T.</given-names></name><name><surname>Bader</surname><given-names>J.S.</given-names></name><name><surname>Ewald</surname><given-names>A.J.</given-names></name></person-group><article-title>Twist1-induced dissemination preserves epithelial identity and requires E-cadherin</article-title><source>J. Cell Biol.</source><year>2014</year><volume>204</volume><fpage>839</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">24590176</pub-id></element-citation></ref><ref id="B118-jcm-08-01092"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaeva</surname><given-names>A.V.</given-names></name><name><surname>Zima</surname><given-names>A.P.</given-names></name><name><surname>Shabalova</surname><given-names>I.P.</given-names></name><name><surname>Ryazantseva</surname><given-names>N.V.</given-names></name><name><surname>Vasil&#x02019;eva</surname><given-names>O.A.</given-names></name><name><surname>Kasoayn</surname><given-names>K.T.</given-names></name><name><surname>Saprina</surname><given-names>T.V.</given-names></name><name><surname>Latypova</surname><given-names>V.N.</given-names></name><name><surname>Berezkina</surname><given-names>I.S.</given-names></name><name><surname>Novitskii</surname><given-names>V.V.</given-names></name></person-group><article-title>&#x003b2;-catenin: Structure, function and role in malignant transformation of epithelial cells (in Russ)</article-title><source>Vestn. Ross. Akad. Meditsinskikh Nauk</source><year>2015</year><volume>70</volume><fpage>475</fpage><lpage>483</lpage></element-citation></ref><ref id="B119-jcm-08-01092"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolly</surname><given-names>M.K.</given-names></name><name><surname>Boareto</surname><given-names>M.</given-names></name><name><surname>Debeb</surname><given-names>B.G.</given-names></name><name><surname>Aceto</surname><given-names>N.</given-names></name><name><surname>Farach-Carson</surname><given-names>M.C.</given-names></name><name><surname>Woodward</surname><given-names>W.A.</given-names></name><name><surname>Levine</surname><given-names>H.</given-names></name></person-group><article-title>Inflammatory breast cancer: A model for investigating cluster-based dissemination</article-title><source>NPJ Breast Cancer</source><year>2017</year><volume>3</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">28232952</pub-id></element-citation></ref><ref id="B120-jcm-08-01092"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedl</surname><given-names>P.</given-names></name><name><surname>Gilmour</surname><given-names>D.</given-names></name></person-group><article-title>Collective cell migration in morphogenesis, regeneration and cancer</article-title><source>Nat. Rev.</source><year>2009</year><volume>10</volume><fpage>455</fpage><lpage>456</lpage></element-citation></ref><ref id="B121-jcm-08-01092"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>R.</given-names></name><name><surname>Alahari</surname><given-names>S.K.</given-names></name></person-group><article-title>Important role of integrins in the cancer biology</article-title><source>Cancer Metastasis Rev.</source><year>2010</year><volume>29</volume><fpage>223</fpage><lpage>237</lpage><?supplied-pmid 20112053?><pub-id pub-id-type="pmid">20112053</pub-id></element-citation></ref><ref id="B122-jcm-08-01092"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huttenlocher</surname><given-names>A.</given-names></name><name><surname>Horwitz</surname><given-names>A.R.</given-names></name></person-group><article-title>Integrins in Cell Migration</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2011</year><fpage>1</fpage><lpage>17</lpage></element-citation></ref><ref id="B123-jcm-08-01092"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>K.K.</given-names></name><name><surname>Pal</surname><given-names>S.</given-names></name><name><surname>Moulik</surname><given-names>S.</given-names></name><name><surname>Chatterjee</surname><given-names>A.</given-names></name></person-group><article-title>Integrins and metastasis</article-title><source>Cell Adhes. Migr.</source><year>2013</year><volume>7</volume><fpage>251</fpage><lpage>261</lpage></element-citation></ref><ref id="B124-jcm-08-01092"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morini</surname><given-names>M.</given-names></name><name><surname>Marcella</surname><given-names>M.</given-names></name><name><surname>Nicoletta</surname><given-names>F.</given-names></name><name><surname>Federica</surname><given-names>G.</given-names></name><name><surname>Simonetta</surname><given-names>B.</given-names></name><name><surname>Roberta</surname><given-names>M.</given-names></name><name><surname>Douglas</surname><given-names>M.N.</given-names></name><name><surname>Pier Giorgio</surname><given-names>N.</given-names></name><name><surname>Adriana</surname><given-names>A.</given-names></name></person-group><article-title>The &#x003b1;3&#x003b2;1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (mmp-9) activity</article-title><source>Int. J. Cancer</source><year>2000</year><volume>87</volume><fpage>336</fpage><lpage>342</lpage><?supplied-pmid 10897037?><pub-id pub-id-type="pmid">10897037</pub-id></element-citation></ref><ref id="B125-jcm-08-01092"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.D.</given-names></name><name><surname>Chen</surname><given-names>Z.Y.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Xiong</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Dong</surname><given-names>J.H.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group><article-title>Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis</article-title><source>Clin. Cancer Res.</source><year>2007</year><volume>13</volume><fpage>3115</fpage><lpage>3124</lpage><?supplied-pmid 17545513?><pub-id pub-id-type="pmid">17545513</pub-id></element-citation></ref><ref id="B126-jcm-08-01092"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seguin</surname><given-names>L.</given-names></name><name><surname>Desgrosellier</surname><given-names>J.S.</given-names></name><name><surname>Weis</surname><given-names>S.M.</given-names></name><name><surname>Cheresh</surname><given-names>D.A.</given-names></name></person-group><article-title>Integrins and cancer: Regulators of cancer stemness, metastasis, and drug resistance</article-title><source>Trends Cell Biol.</source><year>2015</year><volume>25</volume><fpage>234</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">25572304</pub-id></element-citation></ref><ref id="B127-jcm-08-01092"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Giancotti</surname><given-names>F.G.</given-names></name></person-group><article-title>Integrin signalling during tumour progression</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2004</year><volume>5</volume><fpage>816</fpage><lpage>826</lpage><?supplied-pmid 15459662?><pub-id pub-id-type="pmid">15459662</pub-id></element-citation></ref><ref id="B128-jcm-08-01092"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>B.M.</given-names></name><name><surname>Matsuura</surname><given-names>N.</given-names></name><name><surname>Takada</surname><given-names>Y.</given-names></name><name><surname>Zetter</surname><given-names>B.R.</given-names></name><name><surname>Hemler</surname><given-names>M.E.</given-names></name></person-group><article-title>In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells</article-title><source>Science</source><year>1991</year><volume>251</volume><fpage>1600</fpage><lpage>1602</lpage><pub-id pub-id-type="pmid">2011740</pub-id></element-citation></ref><ref id="B129-jcm-08-01092"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desgrosellier</surname><given-names>J.S.</given-names></name><name><surname>Cheresh</surname><given-names>D.A.</given-names></name></person-group><article-title>Integrins in cancer: Biological implications and therapeutic opportunities</article-title><source>Nat. Rev. Cancer</source><year>2010</year><volume>10</volume><fpage>9</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">20029421</pub-id></element-citation></ref><ref id="B130-jcm-08-01092"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Bernard-Trifilo</surname><given-names>J.A.</given-names></name><name><surname>Lim</surname><given-names>Y.</given-names></name><name><surname>Lim</surname><given-names>S.T.</given-names></name><name><surname>Mitra</surname><given-names>S.K.</given-names></name><name><surname>Uryu</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Pallen</surname><given-names>C.J.</given-names></name><name><surname>Cheung</surname><given-names>N.K.V.</given-names></name><name><surname>Mikolon</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Distinct FAK-Src activation events promote &#x003b1;5&#x003b2;1 and &#x003b1;4&#x003b2;1 integrin-stimulated neuroblastoma cell motility</article-title><source>Oncogene</source><year>2008</year><volume>27</volume><fpage>1439</fpage><lpage>1448</lpage><pub-id pub-id-type="pmid">17828307</pub-id></element-citation></ref><ref id="B131-jcm-08-01092"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000f6;ttelndreier</surname><given-names>H.</given-names></name><name><surname>Potter</surname><given-names>B.V.</given-names></name><name><surname>Mayr</surname><given-names>G.W.</given-names></name><name><surname>Guse</surname><given-names>A.H.</given-names></name></person-group><article-title>Mechanisms involved in &#x003b1;6&#x003b2;1-integrin-mediated Ca(2+) signalling</article-title><source>Cell. Signal.</source><year>2001</year><volume>13</volume><fpage>895</fpage><lpage>899</lpage><?supplied-pmid 11728829?><pub-id pub-id-type="pmid">11728829</pub-id></element-citation></ref><ref id="B132-jcm-08-01092"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>O.</given-names></name><name><surname>Suzuki-Inoe</surname><given-names>K.</given-names></name><name><surname>McCarty</surname><given-names>O.J.T.</given-names></name><name><surname>Moroi</surname><given-names>M.</given-names></name><name><surname>Ruggeri</surname><given-names>Z.M.</given-names></name><name><surname>Kunicki</surname><given-names>T.J.</given-names></name></person-group><article-title>Laminin stimulates spreading of platelets through integrin &#x003b1;6&#x003b2;1&#x02013;dependent activation of GPVI</article-title><source>Northwest Sci.</source><year>2006</year><volume>107</volume><fpage>1405</fpage><lpage>1411</lpage></element-citation></ref><ref id="B133-jcm-08-01092"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapoport</surname><given-names>E.M.</given-names></name><name><surname>Kurmyshkina</surname><given-names>O.V.</given-names></name><name><surname>Bovin</surname><given-names>N.V.</given-names></name></person-group><article-title>Mammalian galectins: Structure, carbohydrate specificity, and functions</article-title><source>Biochem.</source><year>2008</year><volume>73</volume><fpage>393</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">18457568</pub-id></element-citation></ref><ref id="B134-jcm-08-01092"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowitz</surname><given-names>A.</given-names></name><name><surname>Kadmon</surname><given-names>G.</given-names></name><name><surname>Verschueren</surname><given-names>H.</given-names></name><name><surname>Remels</surname><given-names>L.</given-names></name><name><surname>De Baetselier</surname><given-names>P.</given-names></name><name><surname>Hubbe</surname><given-names>M.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Schirrmacher</surname><given-names>V.</given-names></name><name><surname>Altevogt</surname><given-names>P.</given-names></name></person-group><article-title>Expression of L1 cell adhesion molecule is associated with lymphoma growth and metastasis</article-title><source>Clin. Exp. Metastasis</source><year>1993</year><volume>11</volume><fpage>419</fpage><lpage>429</lpage><?supplied-pmid 8375117?><pub-id pub-id-type="pmid">8375117</pub-id></element-citation></ref><ref id="B135-jcm-08-01092"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sidenius</surname><given-names>N.</given-names></name><name><surname>Blasi</surname><given-names>F.</given-names></name></person-group><article-title>The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy</article-title><source>Cancer Metastasis Rev.</source><year>2003</year><volume>22</volume><fpage>205</fpage><lpage>222</lpage><?supplied-pmid 12784997?><pub-id pub-id-type="pmid">12784997</pub-id></element-citation></ref><ref id="B136-jcm-08-01092"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banys-Paluchowski</surname><given-names>M.</given-names></name><name><surname>Witzel</surname><given-names>I.</given-names></name><name><surname>Aktas</surname><given-names>B.</given-names></name><name><surname>Fasching</surname><given-names>P.A.</given-names></name><name><surname>Hartkopf</surname><given-names>A.</given-names></name><name><surname>Janni</surname><given-names>W.</given-names></name><name><surname>Kasimir-Bauer</surname><given-names>S.</given-names></name><name><surname>Pantel</surname><given-names>K.</given-names></name><name><surname>Sch&#x000f6;n</surname><given-names>G.</given-names></name><name><surname>Rack</surname><given-names>B.</given-names></name><etal/></person-group><article-title>The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">30626917</pub-id></element-citation></ref><ref id="B137-jcm-08-01092"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pav&#x000f3;n</surname><given-names>M.A.</given-names></name><name><surname>Arroyo-Solera</surname><given-names>I.</given-names></name><name><surname>C&#x000e9;spedes</surname><given-names>M.V.</given-names></name><name><surname>Casanova</surname><given-names>I.</given-names></name><name><surname>Le&#x000f3;n</surname><given-names>X.</given-names></name><name><surname>Mangues</surname><given-names>R.</given-names></name></person-group><article-title>uPA/uPAR and SERPINE1 in head and neck cancer: Role in tumor resistance, metastasis, prognosis and therapy</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>57351</fpage><lpage>57366</lpage><pub-id pub-id-type="pmid">27385000</pub-id></element-citation></ref><ref id="B138-jcm-08-01092"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozzuto</surname><given-names>G.</given-names></name><name><surname>Ruggieri</surname><given-names>P.</given-names></name><name><surname>Molinari</surname><given-names>A.</given-names></name></person-group><article-title>Molecular aspects of tumor cell migration and invasion</article-title><source>Ann Ist Super Sanita</source><year>2010</year><volume>46</volume><fpage>66</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">20348621</pub-id></element-citation></ref><ref id="B139-jcm-08-01092"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohtasham</surname><given-names>N.</given-names></name><name><surname>Babakoohi</surname><given-names>S.</given-names></name><name><surname>Shiva</surname><given-names>A.</given-names></name><name><surname>Shadman</surname><given-names>A.</given-names></name><name><surname>Kamyab-Hesari</surname><given-names>K.</given-names></name><name><surname>Shakeri</surname><given-names>M.-T.</given-names></name><name><surname>Sharifi-Sistan</surname><given-names>N.</given-names></name></person-group><article-title>Immunohistochemical study of p53, Ki-67, MMP-2 and MMP-9 expression at invasive front of squamous cell and verrucous carcinoma in oral cavity</article-title><source>Pathol. Res. Pract.</source><year>2013</year><volume>209</volume><fpage>110</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">23273944</pub-id></element-citation></ref><ref id="B140-jcm-08-01092"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>D.</given-names></name><name><surname>Cambier</surname><given-names>S.</given-names></name><name><surname>Fjellbirkeland</surname><given-names>L.</given-names></name><name><surname>Baron</surname><given-names>J.L.</given-names></name><name><surname>Munger</surname><given-names>J.S.</given-names></name><name><surname>Kawakatsu</surname><given-names>H.</given-names></name><name><surname>Sheppard</surname><given-names>D.</given-names></name><name><surname>Courtney Broaddus</surname><given-names>V.</given-names></name><name><surname>Nishimura</surname><given-names>S.L.</given-names></name></person-group><article-title>The integrin &#x003b1;&#x003bd;&#x003b2;8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-&#x003b2;1</article-title><source>J. Cell Biol.</source><year>2002</year><volume>157</volume><fpage>493</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">11970960</pub-id></element-citation></ref><ref id="B141-jcm-08-01092"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Q.</given-names></name><name><surname>Stamenkovic</surname><given-names>I.</given-names></name></person-group><article-title>Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-&#x003b2; and promotes tumor invasion and angiogenesis</article-title><source>Genes Dev.</source><year>2000</year><volume>14</volume><fpage>163</fpage><lpage>176</lpage><?supplied-pmid 10652271?><pub-id pub-id-type="pmid">10652271</pub-id></element-citation></ref><ref id="B142-jcm-08-01092"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatti</surname><given-names>O.</given-names></name><name><surname>Vehvil&#x000e4;inen</surname><given-names>P.</given-names></name><name><surname>Lehti</surname><given-names>K.</given-names></name><name><surname>Keski-Oja</surname><given-names>J.</given-names></name></person-group><article-title>MT1-MMP releases latent TGF-&#x003b2;1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1</article-title><source>Exp. Cell Res.</source><year>2008</year><volume>314</volume><fpage>2501</fpage><lpage>2514</lpage><?supplied-pmid 18602101?><pub-id pub-id-type="pmid">18602101</pub-id></element-citation></ref><ref id="B143-jcm-08-01092"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsiades</surname><given-names>N.</given-names></name><name><surname>Yu</surname><given-names>W.H.</given-names></name><name><surname>Poulaki</surname><given-names>V.</given-names></name><name><surname>Tsokos</surname><given-names>M.</given-names></name><name><surname>Stamenkovic</surname><given-names>I.</given-names></name></person-group><article-title>Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity</article-title><source>Cancer Res.</source><year>2001</year><volume>61</volume><fpage>577</fpage><lpage>581</lpage><?supplied-pmid 11212252?><pub-id pub-id-type="pmid">11212252</pub-id></element-citation></ref><ref id="B144-jcm-08-01092"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergers</surname><given-names>G.</given-names></name><name><surname>Brekken</surname><given-names>R.</given-names></name><name><surname>McMahon</surname><given-names>G.</given-names></name><name><surname>Vu</surname><given-names>T.H.</given-names></name><name><surname>Itoh</surname><given-names>T.</given-names></name><name><surname>Tamaki</surname><given-names>K.</given-names></name><name><surname>Tanzawa</surname><given-names>K.</given-names></name><name><surname>Thorpe</surname><given-names>P.</given-names></name><name><surname>Itohara</surname><given-names>S.</given-names></name><name><surname>Werb</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis</article-title><source>Nat. Cell Biol.</source><year>2000</year><volume>2</volume><fpage>737</fpage><lpage>744</lpage><?supplied-pmid 11025665?><pub-id pub-id-type="pmid">11025665</pub-id></element-citation></ref><ref id="B145-jcm-08-01092"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>G.O.</given-names></name><name><surname>Brown</surname><given-names>J.M.</given-names></name></person-group><article-title>Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells</article-title><source>Cancer Cell</source><year>2008</year><volume>13</volume><fpage>193</fpage><lpage>205</lpage><?supplied-pmid 18328424?><pub-id pub-id-type="pmid">18328424</pub-id></element-citation></ref><ref id="B146-jcm-08-01092"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardi</surname><given-names>V.C.</given-names></name><name><surname>Kupriyanova</surname><given-names>T.A.</given-names></name><name><surname>Deryugina</surname><given-names>E.I.</given-names></name><name><surname>Quigley</surname><given-names>J.P.</given-names></name></person-group><article-title>Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis</article-title><source>Proc. Natl. Acad. Sci.</source><year>2007</year><volume>104</volume><fpage>20262</fpage><lpage>20267</lpage><?supplied-pmid 18077379?><pub-id pub-id-type="pmid">18077379</pub-id></element-citation></ref><ref id="B147-jcm-08-01092"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>H.</given-names></name><name><surname>Condeelis</surname><given-names>J.</given-names></name></person-group><article-title>Regulation of the actin cytoskeleton in cancer cell migration and invasion</article-title><source>Biochim. Biophys. Acta</source><year>2007</year><fpage>642</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">16926057</pub-id></element-citation></ref><ref id="B148-jcm-08-01092"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clucas</surname><given-names>J.</given-names></name><name><surname>Valderrama</surname><given-names>F.</given-names></name></person-group><article-title>ERM proteins in cancer progression</article-title><source>J. Cell Sci.</source><year>2015</year><volume>128</volume><fpage>1253</fpage><?supplied-pmid 25774052?><pub-id pub-id-type="pmid">25774052</pub-id></element-citation></ref><ref id="B149-jcm-08-01092"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;n-Villar</surname><given-names>E.</given-names></name><name><surname>Scholl</surname><given-names>F.G.</given-names></name><name><surname>Gamallo</surname><given-names>C.</given-names></name><name><surname>Yurrita</surname><given-names>M.M.</given-names></name><name><surname>Mu&#x000f1;oz-Guerra</surname><given-names>M.</given-names></name><name><surname>Cruces</surname><given-names>J.</given-names></name><name><surname>Quintanilla</surname><given-names>M.</given-names></name></person-group><article-title>Characterization of human PA2.26 antigen (T1&#x003b1;-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas</article-title><source>Int. J. Cancer</source><year>2005</year><volume>113</volume><fpage>899</fpage><lpage>910</lpage><?supplied-pmid 15515019?><pub-id pub-id-type="pmid">15515019</pub-id></element-citation></ref><ref id="B150-jcm-08-01092"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehon</surname><given-names>R.G.</given-names></name><name><surname>McClatchey</surname><given-names>A.I.</given-names></name><name><surname>Bretscher</surname><given-names>A.</given-names></name></person-group><article-title>Organizing the cell cortex: The role of ERM proteins</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2010</year><volume>11</volume><fpage>276</fpage><lpage>287</lpage><?supplied-pmid 20308985?><pub-id pub-id-type="pmid">20308985</pub-id></element-citation></ref><ref id="B151-jcm-08-01092"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>E.S.</given-names></name><name><surname>Brown</surname><given-names>B.</given-names></name><name><surname>Whigham</surname><given-names>A.S.</given-names></name><name><surname>Kochaishvili</surname><given-names>A.</given-names></name><name><surname>Yarbrough</surname><given-names>W.G.</given-names></name><name><surname>Weaver</surname><given-names>A.M.</given-names></name></person-group><article-title>Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon</article-title><source>Oncogene</source><year>2009</year><volume>28</volume><fpage>431</fpage><lpage>444</lpage><?supplied-pmid 18931703?><pub-id pub-id-type="pmid">18931703</pub-id></element-citation></ref><ref id="B152-jcm-08-01092"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roussos</surname><given-names>E.T.</given-names></name><name><surname>Balsamo</surname><given-names>M.</given-names></name><name><surname>Alford</surname><given-names>S.K.</given-names></name><name><surname>Wyckoff</surname><given-names>J.B.</given-names></name><name><surname>Gligorijevic</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Pozzuto</surname><given-names>M.</given-names></name><name><surname>Stobezki</surname><given-names>R.</given-names></name><name><surname>Goswami</surname><given-names>S.</given-names></name><name><surname>Segall</surname><given-names>J.E.</given-names></name><etal/></person-group><article-title>Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer</article-title><source>J. Cell Sci.</source><year>2011</year><volume>124</volume><fpage>2120</fpage><lpage>2131</lpage><?supplied-pmid 21670198?><pub-id pub-id-type="pmid">21670198</pub-id></element-citation></ref><ref id="B153-jcm-08-01092"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weidmann</surname><given-names>M.D.</given-names></name><name><surname>Surve</surname><given-names>C.R.</given-names></name><name><surname>Eddy</surname><given-names>R.J.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Gertler</surname><given-names>F.B.</given-names></name><name><surname>Sharma</surname><given-names>V.P.</given-names></name><name><surname>Condeelis</surname><given-names>J.S.</given-names></name></person-group><article-title>MenaINV dysregulates cortactin phosphorylation to promote invadopodium maturation</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">28442746</pub-id></element-citation></ref><ref id="B154-jcm-08-01092"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machesky</surname><given-names>L.M.</given-names></name><name><surname>Li</surname><given-names>A.</given-names></name></person-group><article-title>Fascin</article-title><source>Commun. Integr. Biol.</source><year>2010</year><volume>3</volume><fpage>263</fpage><lpage>270</lpage><?supplied-pmid 20714410?><pub-id pub-id-type="pmid">20714410</pub-id></element-citation></ref><ref id="B155-jcm-08-01092"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papaspyrou</surname><given-names>K.</given-names></name><name><surname>Brochhausen</surname><given-names>C.</given-names></name><name><surname>Schmidtmann</surname><given-names>I.</given-names></name><name><surname>Fruth</surname><given-names>K.</given-names></name><name><surname>Gouveris</surname><given-names>H.</given-names></name><name><surname>Kirckpatrick</surname><given-names>J.</given-names></name><name><surname>Mann</surname><given-names>W.</given-names></name><name><surname>Brieger</surname><given-names>J.</given-names></name></person-group><article-title>Fascin upregulation in primary head and neck squamous cell carcinoma is associated with lymphatic metastasis</article-title><source>Oncol. Lett.</source><year>2014</year><volume>7</volume><fpage>2041</fpage><lpage>2046</lpage><?supplied-pmid 24932286?><pub-id pub-id-type="pmid">24932286</pub-id></element-citation></ref><ref id="B156-jcm-08-01092"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovisa</surname><given-names>S.</given-names></name><name><surname>LeBleu</surname><given-names>V.S.</given-names></name><name><surname>Tampe</surname><given-names>B.</given-names></name><name><surname>Sugimoto</surname><given-names>H.</given-names></name><name><surname>Vadnagara</surname><given-names>K.</given-names></name><name><surname>Carstens</surname><given-names>J.L.</given-names></name><name><surname>Wu</surname><given-names>C.C.</given-names></name><name><surname>Hagos</surname><given-names>Y.</given-names></name><name><surname>Burckhardt</surname><given-names>B.C.</given-names></name><name><surname>Pentcheva-Hoang</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis</article-title><source>Nat. Med.</source><year>2015</year><volume>21</volume><fpage>998</fpage><lpage>1009</lpage><?supplied-pmid 26236991?><pub-id pub-id-type="pmid">26236991</pub-id></element-citation></ref><ref id="B157-jcm-08-01092"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>A.L.</given-names></name><name><surname>Jackson</surname><given-names>T.L.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Rohlf</surname><given-names>T.</given-names></name></person-group><article-title>Receptor cross-talk in angiogenesis: Mapping environmental cues to cell phenotype using a stochastic, Boolean signaling network model</article-title><source>J. Theor. Biol.</source><year>2010</year><volume>264</volume><fpage>838</fpage><lpage>846</lpage><?supplied-pmid 20307549?><pub-id pub-id-type="pmid">20307549</pub-id></element-citation></ref><ref id="B158-jcm-08-01092"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zavyalova</surname><given-names>M.V.</given-names></name><name><surname>Perelmuter</surname><given-names>V.M.</given-names></name><name><surname>Slonimskaya</surname><given-names>E.M.</given-names></name><name><surname>Vtorushin</surname><given-names>S.V.</given-names></name><name><surname>Garbukov</surname><given-names>E.Y.</given-names></name><name><surname>Gluschenko</surname><given-names>S.A.</given-names></name></person-group><article-title>Conjugation of lymphogenous metastatic spread and histologic pattern of infiltrative component of ductal breast cancer (in Russ)</article-title><source>Sib. J. Oncol.</source><year>2006</year><volume>1</volume><fpage>32</fpage><lpage>35</lpage></element-citation></ref><ref id="B159-jcm-08-01092"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perelmuter</surname><given-names>V.M.</given-names></name><name><surname>Zavyalova</surname><given-names>M.V.</given-names></name><name><surname>Slonimskaya</surname><given-names>E.M.</given-names></name><name><surname>Vtorushin</surname><given-names>S.V.</given-names></name><name><surname>Garbukov</surname><given-names>E.Y.</given-names></name></person-group><article-title>Hematogenous metastasis depending on histologic tumor pattern in breast cancer (In Russ)</article-title><source>Sib. J. Oncol.</source><year>2006</year><volume>3</volume><fpage>29</fpage><lpage>33</lpage></element-citation></ref><ref id="B160-jcm-08-01092"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denisov</surname><given-names>E.V.</given-names></name><name><surname>Skryabin</surname><given-names>N.A.</given-names></name><name><surname>Gerashchenko</surname><given-names>T.S.</given-names></name><name><surname>Tashireva</surname><given-names>L.A.</given-names></name><name><surname>Wilhelm</surname><given-names>J.</given-names></name><name><surname>Buldakov</surname><given-names>M.A.</given-names></name><name><surname>Sleptcov</surname><given-names>A.A.</given-names></name><name><surname>Lebedev</surname><given-names>I.N.</given-names></name><name><surname>Vtorushin</surname><given-names>S.V.</given-names></name><name><surname>Zavyalova</surname><given-names>M.V.</given-names></name><etal/></person-group><article-title>Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44<sup>+</sup>CD24<sup>&#x02212;</sup> stemness</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>61163</fpage><lpage>61180</lpage><pub-id pub-id-type="pmid">28977854</pub-id></element-citation></ref><ref id="B161-jcm-08-01092"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zavyalova</surname><given-names>M.V.</given-names></name><name><surname>Perelmuter</surname><given-names>V.M.</given-names></name><name><surname>Vtorushin</surname><given-names>S.V.</given-names></name><name><surname>Denisov</surname><given-names>E.V.</given-names></name><name><surname>Litvyakov</surname><given-names>N.V.</given-names></name><name><surname>Slonimskaya</surname><given-names>E.M.</given-names></name><name><surname>Cherdyntseva</surname><given-names>N.V.</given-names></name></person-group><article-title>The Presence of Alveolar Structures in Invasive Ductal NOS Breast Carcinoma is Associated with Lymph Node Metastasis</article-title><source>Diagn. Cytopathol.</source><year>2013</year><volume>41</volume><fpage>279</fpage><lpage>282</lpage><?supplied-pmid 22102485?><pub-id pub-id-type="pmid">22102485</pub-id></element-citation></ref><ref id="B162-jcm-08-01092"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerashchenko</surname><given-names>T.S.</given-names></name><name><surname>Zavyalova</surname><given-names>M.V.</given-names></name><name><surname>Denisov</surname><given-names>E.V.</given-names></name><name><surname>Krakhmal</surname><given-names>N.V.</given-names></name><name><surname>Pautova</surname><given-names>D.N.</given-names></name><name><surname>Litviakov</surname><given-names>N.V.</given-names></name><name><surname>Vtorushin</surname><given-names>S.V.</given-names></name><name><surname>Cherdyntseva</surname><given-names>N.V.</given-names></name><name><surname>Perelmuter</surname><given-names>V.M.</given-names></name></person-group><article-title>Intratumoral morphological heterogeneity of breast cancer as an indicator of the metastatic potential and tumor chemosensitivity</article-title><source>Acta Naturae</source><year>2017</year><volume>9</volume><fpage>56</fpage><lpage>67</lpage><?supplied-pmid 28461975?><pub-id pub-id-type="pmid">28461975</pub-id></element-citation></ref><ref id="B163-jcm-08-01092"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denisov</surname><given-names>E.V.</given-names></name><name><surname>Litviakov</surname><given-names>N.V.</given-names></name><name><surname>Zavyalova</surname><given-names>M.V.</given-names></name><name><surname>Perelmuter</surname><given-names>V.M.</given-names></name><name><surname>Vtorushin</surname><given-names>S.V.</given-names></name><name><surname>Tsyganov</surname><given-names>M.M.</given-names></name><name><surname>Gerashchenko</surname><given-names>T.S.</given-names></name><name><surname>Garbukov</surname><given-names>E.Y.</given-names></name><name><surname>Slonimskaya</surname><given-names>E.M.</given-names></name><name><surname>Cherdyntseva</surname><given-names>N.V.</given-names></name></person-group><article-title>Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression</article-title><source>Sci. Rep.</source><year>2014</year><volume>4</volume><fpage>1</fpage><lpage>7</lpage></element-citation></ref></ref-list></back><floats-group><fig id="jcm-08-01092-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Two types of breast carcinomas based on a structural pattern. Nonstructural breast carcinomas are represented by large solid fields of cells connected to each other. Structural breast carcinomas are characterized by a phenotypic variety of the infiltrative (invasive) component, represented by certain types of morphological arrangements of tumor cells: Tubular structures, solid structures with small sprouts, solid structures with large torpedo-like sprouts, alveolar structures, torpedo-like structures, trabecular structures, and discrete groups of tumor cells. The images of hematoxylin and eosin-stained sections were obtained from the database of the Department of Pathological Anatomy, Siberian State Medical University, Tomsk, Russia.</p></caption><graphic xlink:href="jcm-08-01092-g001"/></fig><table-wrap id="jcm-08-01092-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">jcm-08-01092-t001_Table 1</object-id><label>Table 1</label><caption><p>Potential markers of cancer cell invasion.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Markers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Functions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Expression at the Invasive Front</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Limitations</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">ECM components</td><td align="center" valign="middle" rowspan="1" colspan="1">Laminin-5, &#x003b3;2 chain</td><td rowspan="2" align="center" valign="middle" colspan="1">ECM components, triggering MMP production through interaction with integrins</td><td align="center" valign="middle" rowspan="1" colspan="1">Breast, pancreatic, colon, lung, and other cancers [<xref rid="B46-jcm-08-01092" ref-type="bibr">46</xref>,<xref rid="B51-jcm-08-01092" ref-type="bibr">51</xref>,<xref rid="B52-jcm-08-01092" ref-type="bibr">52</xref>,<xref rid="B55-jcm-08-01092" ref-type="bibr">55</xref>,<xref rid="B56-jcm-08-01092" ref-type="bibr">56</xref>]</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Expression not only in the invasive front, but in other regions of the tumor [<xref rid="B43-jcm-08-01092" ref-type="bibr">43</xref>,<xref rid="B46-jcm-08-01092" ref-type="bibr">46</xref>,<xref rid="B57-jcm-08-01092" ref-type="bibr">57</xref>,<xref rid="B58-jcm-08-01092" ref-type="bibr">58</xref>,<xref rid="B59-jcm-08-01092" ref-type="bibr">59</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fibronectin</td><td align="center" valign="middle" rowspan="1" colspan="1">Oral and head and neck cancers [<xref rid="B60-jcm-08-01092" ref-type="bibr">60</xref>,<xref rid="B61-jcm-08-01092" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tenascin C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Modulation of cell adhesion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanoma, breast, lung, liver, and gallbladder cancers [<xref rid="B57-jcm-08-01092" ref-type="bibr">57</xref>,<xref rid="B62-jcm-08-01092" ref-type="bibr">62</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EMT molecules</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Snail, Twist, vimentin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EMT induction and regulation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Various cancers [<xref rid="B63-jcm-08-01092" ref-type="bibr">63</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Snail and Twist: Unstable molecules [<xref rid="B64-jcm-08-01092" ref-type="bibr">64</xref>,<xref rid="B65-jcm-08-01092" ref-type="bibr">65</xref>], total expression in breast tumors [<xref rid="B66-jcm-08-01092" ref-type="bibr">66</xref>]. Vimentin may not be expressed in invasive carcinomas [<xref rid="B67-jcm-08-01092" ref-type="bibr">67</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Cell&#x02013;cell and cell&#x02013;ECM interaction molecules</td><td align="center" valign="middle" rowspan="1" colspan="1">Cadherin-catenin complex</td><td align="center" valign="middle" rowspan="1" colspan="1">Adherens junctions</td><td align="center" valign="middle" rowspan="1" colspan="1">Colorectal, oral, and basaloid carcinomas (loss of E-cadherin and nuclear localization of &#x003b2;-catenin) [<xref rid="B68-jcm-08-01092" ref-type="bibr">68</xref>,<xref rid="B69-jcm-08-01092" ref-type="bibr">69</xref>,<xref rid="B70-jcm-08-01092" ref-type="bibr">70</xref>,<xref rid="B71-jcm-08-01092" ref-type="bibr">71</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">In some tumors, loss of E-cadherin is not indispensable for invasive growth [<xref rid="B72-jcm-08-01092" ref-type="bibr">72</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Integrins</td><td align="center" valign="middle" rowspan="1" colspan="1">Cell&#x02013;ECM adhesion, involvement in MMP production</td><td align="center" valign="middle" rowspan="1" colspan="1">Melanoma (&#x003b1;v&#x003b2;3), colon (&#x003b1;v&#x003b2;6), head and neck (&#x003b1;v&#x003b2;6), and lung (&#x003b1;6&#x003b2;4) cancers [<xref rid="B73-jcm-08-01092" ref-type="bibr">73</xref>,<xref rid="B74-jcm-08-01092" ref-type="bibr">74</xref>,<xref rid="B75-jcm-08-01092" ref-type="bibr">75</xref>,<xref rid="B76-jcm-08-01092" ref-type="bibr">76</xref>]</td><td rowspan="2" align="center" valign="middle" colspan="1">Involvement in other biological processes [<xref rid="B77-jcm-08-01092" ref-type="bibr">77</xref>,<xref rid="B78-jcm-08-01092" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Galectin 1</td><td align="center" valign="middle" rowspan="1" colspan="1">Modulation of cell&#x02013;cell and cell&#x02013;ECM interactions</td><td align="center" valign="middle" rowspan="1" colspan="1">Oral and lung cancers, glioblastoma [<xref rid="B47-jcm-08-01092" ref-type="bibr">47</xref>,<xref rid="B79-jcm-08-01092" ref-type="bibr">79</xref>,<xref rid="B80-jcm-08-01092" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L1CAM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell adhesion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Colorectal and pancreatic cancers [<xref rid="B81-jcm-08-01092" ref-type="bibr">81</xref>,<xref rid="B82-jcm-08-01092" ref-type="bibr">82</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dualistic role in cancer progression [<xref rid="B83-jcm-08-01092" ref-type="bibr">83</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Serine proteases and MMPs</td><td align="center" valign="middle" rowspan="1" colspan="1">uPA</td><td align="center" valign="middle" rowspan="1" colspan="1">Proteolysis of plasminogen to plasmin</td><td align="center" valign="middle" rowspan="1" colspan="1">Oral and skin carcinomas [<xref rid="B84-jcm-08-01092" ref-type="bibr">84</xref>,<xref rid="B85-jcm-08-01092" ref-type="bibr">85</xref>]</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Involvement in other biological processes [<xref rid="B86-jcm-08-01092" ref-type="bibr">86</xref>,<xref rid="B87-jcm-08-01092" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMPs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ECM proteolysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanoma (MMP-2), colorectal (MMP-7), gastric (MMP-7), endometrial (MMP-2, 9), ovarian (MMP-2, 9), and head and neck (MMP-2, 9) cancers [<xref rid="B56-jcm-08-01092" ref-type="bibr">56</xref>,<xref rid="B88-jcm-08-01092" ref-type="bibr">88</xref>,<xref rid="B89-jcm-08-01092" ref-type="bibr">89</xref>,<xref rid="B90-jcm-08-01092" ref-type="bibr">90</xref>,<xref rid="B91-jcm-08-01092" ref-type="bibr">91</xref>,<xref rid="B92-jcm-08-01092" ref-type="bibr">92</xref>,<xref rid="B93-jcm-08-01092" ref-type="bibr">93</xref>,<xref rid="B94-jcm-08-01092" ref-type="bibr">94</xref>]</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Actin cytoskeleton proteins</td><td align="center" valign="middle" rowspan="1" colspan="1">Ezrin</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Actin polymerization, cytoskeletal dynamics</td><td align="center" valign="middle" rowspan="1" colspan="1">Lung cancer [<xref rid="B95-jcm-08-01092" ref-type="bibr">95</xref>,<xref rid="B96-jcm-08-01092" ref-type="bibr">96</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Involvement in other biological processes. Contradictory data on the role in cancer progression [<xref rid="B96-jcm-08-01092" ref-type="bibr">96</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">WAVE2</td><td align="center" valign="middle" rowspan="1" colspan="1">Breast cancer [<xref rid="B97-jcm-08-01092" ref-type="bibr">97</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cortactin</td><td align="center" valign="middle" rowspan="1" colspan="1">Oral and laryngeal cancers [<xref rid="B98-jcm-08-01092" ref-type="bibr">98</xref>,<xref rid="B99-jcm-08-01092" ref-type="bibr">99</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">MENAinv</td><td align="center" valign="middle" rowspan="1" colspan="1">Breast cancer [<xref rid="B100-jcm-08-01092" ref-type="bibr">100</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fascin-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver, colon, cervical, and endometrial cancers [<xref rid="B101-jcm-08-01092" ref-type="bibr">101</xref>,<xref rid="B102-jcm-08-01092" ref-type="bibr">102</xref>,<xref rid="B103-jcm-08-01092" ref-type="bibr">103</xref>,<xref rid="B104-jcm-08-01092" ref-type="bibr">104</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Other proteins</td><td align="center" valign="middle" rowspan="1" colspan="1">Ki-67</td><td align="center" valign="middle" rowspan="1" colspan="1">Cell proliferation</td><td align="center" valign="middle" rowspan="1" colspan="1">Breast, oral, and endometrial cancers [<xref rid="B6-jcm-08-01092" ref-type="bibr">6</xref>,<xref rid="B105-jcm-08-01092" ref-type="bibr">105</xref>,<xref rid="B106-jcm-08-01092" ref-type="bibr">106</xref>,<xref rid="B107-jcm-08-01092" ref-type="bibr">107</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">Contradictory data on the level of Ki-67 expression at the invasive front [<xref rid="B56-jcm-08-01092" ref-type="bibr">56</xref>,<xref rid="B69-jcm-08-01092" ref-type="bibr">69</xref>,<xref rid="B108-jcm-08-01092" ref-type="bibr">108</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FGFR2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell division, growth and differentiation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Colorectal and cervical cancers [<xref rid="B109-jcm-08-01092" ref-type="bibr">109</xref>,<xref rid="B110-jcm-08-01092" ref-type="bibr">110</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Involvement in other biological processes [<xref rid="B111-jcm-08-01092" ref-type="bibr">111</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>ECM, extracellular matrix; EMT, epithelial&#x02013;mesenchymal transition; MMPs, matrix metalloproteinases.</p></fn></table-wrap-foot></table-wrap></floats-group></article>